Haematologica | haematologica H Ha Hae Haem BLOCKSTART PAGESTART NEWFONT HIGHERFONT 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 0 0 no 0 10 0 0 1 1 0
2500 2500 2500 2 25 250 2500 BLOCKSTART PAGEIN NEWFONT HIGHERFONT 1 0 NOCAPS ALLDIGIT 0 0 0 0 1 0 0 0 0 0 no 0 10 0 0 0 0 0
-Hematopoiesis -Hematopoiesis -hematopoiesis - -H -He -Hem BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 0 - 1 10 0 0 0 0 0
ARTICLE ARTICLE article A AR ART ARTI BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 1 0 0 0 0 0 0 0 no 0 5 0 0 0 0 0
D-2-hydroxyglutarate supports d-2-hydroxyglutarate D D- D-2 D-2- BLOCKSTART PAGEIN NEWFONT HIGHERFONT 1 0 INITCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 0 0 -- 2 10 0 0 0 0 1
with lowered with w wi wit with BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 no 0 10 0 1 0 0 1
in non-malignant in i in in in BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 0 0 - 1 8 0 1 0 0 1
leukemia cells leukemia l le leu leuk BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 0 no 0 10 0 1 0 0 1
Kathrin Hammon, kathrin K Ka Kat Kath BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 1 0 0 0 0 0 0 0 0 ,,*,-*,,, 9 10 0 1 0 0 1
Sonja-Maria Decking, sonja-maria S So Son Sonj BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 0 1 -,.,,, 6 10 1 1 0 0 1
Mendes, 1° mendes, M Me Men Mend BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 0 1 ,,,,., 6 10 1 1 0 0 1
Dettmer, 5 dettmer, D De Det Dett BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 0 1 ,,,,,., 7 10 1 1 0 0 1
Michael Rehli, michael M Mi Mic Mich BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 0 0 0 0 0 0 0 2 ,,,#,# 6 10 1 1 0 0 1
1 1 1 1 1 1 1 BLOCKSTART PAGEIN SAMEFONT LOWERFONT 0 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 0 2 no 0 10 1 0 0 0 1
Department of department D De Dep Depa BLOCKSTART PAGEIN SAMEFONT HIGHERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 2 ,,;- 4 10 1 0 0 0 1
Leibniz Institute leibniz L Le Lei Leib BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 0 2 ,;, 3 10 1 0 0 0 1
University Hospital university U Un Uni Univ BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 2 ,;, 3 10 1 0 0 0 1
Regensburg, Regensburg; regensburg, R Re Reg Rege BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 0 2 ,;,, 4 10 1 0 0 0 1
Regensburg and regensburg R Re Reg Rege BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 0 3 ,, 2 10 1 0 0 0 1
Heidelberg, Mannheim, heidelberg, H He Hei Heid BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 0 3 ,, 2 10 1 0 0 0 1
* * * * * * * BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 1 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 0 3 * 1 10 1 0 0 0 1
KH and kh K KH KH KH BLOCKSTART PAGEIN SAMEFONT HIGHERFONT 0 1 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 0 3 . 1 10 1 0 0 0 1
# # # # # # # BLOCKSTART PAGEIN SAMEFONT LOWERFONT 0 1 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 0 3 # 1 10 1 0 0 0 1
ST and st S ST ST ST BLOCKSTART PAGEIN SAMEFONT HIGHERFONT 0 1 ALLCAP NODIGIT 0 1 0 0 0 0 0 0 0 3 . 1 10 1 0 0 0 1
°Current affiliation: °current ° °C °Cu °Cur BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 3 :, 2 10 0 0 0 0 1
Health (CIIS), health H He Hea Heal BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 1 INITCAP NODIGIT 0 1 1 0 0 0 0 0 0 4 (),(),, 7 10 0 0 0 0 1
Abstract Abstract abstract A Ab Abs Abst BLOCKSTART PAGEIN NEWFONT HIGHERFONT 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 4 no 0 10 0 0 0 0 1
D-2-hydroxyglutarate (D-2-HG) d-2-hydroxyglutarate D D- D-2 D-2- BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 INITCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 0 4 --(--)()- 9 9 0 0 0 0 1
drogenase (IDH) drogenase d dr dro drog BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 4 ().---- 7 9 0 0 0 0 1
tial effects tial t ti tia tial BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 4 -.--- 5 9 0 0 0 0 1
ferentiation, resulting ferentiation, f fe fer fere BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 4 ,., 3 10 0 0 0 0 1
IDH-mutated AML idh-mutated I ID IDH IDH- BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 0 4 ---- 4 9 0 0 0 0 1
cells. Interestingly, cells. c ce cel cell BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 4 .,,-- 5 9 0 0 0 0 1
lactate production lactate l la lac lact BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 4 .,- 3 9 0 0 0 0 1
min C min m mi min min BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 0 0 0 0 0 0 0 4 . 1 9 0 0 0 0 1
Our results our O Ou Our Our BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 4 - 1 9 0 0 0 0 1
potentially novel potentially p po pot pote BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 4 -(- 3 9 0 0 0 0 1
ating agents) ating a at ati atin BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 4 ). 2 4 0 0 0 0 1
Introduction Introduction introduction I In Int Intr BLOCKSTART PAGEIN NEWFONT HIGHERFONT 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 7 no 0 10 0 1 0 0 1
Heterozygous somatic heterozygous H He Het Hete BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 0 7 - 1 8 0 1 0 0 1
nase (IDH) nase n na nas nase BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 7 () 2 10 0 1 0 0 1
and acute and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 7 (),- 4 8 0 1 0 0 1
tected in tected t te tec tect BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 7 . 1 9 0 1 0 0 1
and IDH2 and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 7 -- 2 8 0 1 0 0 1
tarate (α-KG) tarate t ta tar tara BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 7 (-)-- 5 9 0 1 0 0 1
(D-2-HG), which (d-2-hg), ( (D (D- (D-2 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 0 7 (--), 5 9 0 1 0 0 1
sera of sera s se ser sera BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 7 .- 2 9 0 1 0 0 1
levels range levels l le lev leve BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 9 -, 2 9 0 1 0 0 1
patients range patients p pa pat pati BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 9 -. 2 9 0 1 0 0 1
mutations, elevated mutations, m mu mut muta BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 9 ,- 2 9 0 1 0 0 1
in other in i in in in BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 0 9 .,- 3 9 0 1 0 0 1
sion triggers sion s si sio sion BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 9 no 0 10 0 1 0 0 1
in 2-HG in i in in in BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 0 9 -,, 3 9 0 1 0 0 1
the L-enantiomer the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 9 -- 2 8 0 1 0 0 1
expression of expression e ex exp expr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 9 --. 3 9 0 1 0 0 1
Moreover, other moreover, M Mo Mor More BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 9 , 1 9 0 1 0 0 1
lactate dehydrogenase lactate l la lac lact BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 9 () 2 9 0 1 0 0 1
Correspondence: M. correspondence: C Co Cor Corr BLOCKSTART PAGEIN NEWFONT LOWERFONT 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 11 :. 2 10 1 1 0 0 1
marina.kreutz@ukr.de marina.kreutz@ukr.de marina.kreutz@ukr.de m ma mar mari BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 1 0 0 11 .@. 3 10 1 1 0 0 1
Received: Received: received: R Re Rec Rece BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 11 : 1 5 1 1 0 0 1
May 25, may M Ma May May BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 1 1 0 0 1 0 0 0 11 ,. 2 7 1 1 0 0 1
Accepted: Accepted: accepted: A Ac Acc Acce BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 11 : 1 5 1 1 0 0 1
January 11, january J Ja Jan Janu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 1 0 0 0 1 0 0 0 11 ,. 2 10 1 1 0 0 1
Early view: early E Ea Ear Earl BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 1 1 0 0 0 0 0 0 11 : 1 6 1 1 0 0 1
January 18, january J Ja Jan Janu BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 1 0 0 0 1 0 0 0 11 ,. 2 10 1 1 0 0 1
https://doi.org/10.3324/haematol.2023.283597 https://doi.org/10.3324/haematol.2023.283597 https://doi.org/10.3324/haematol.2023.283597 h ht htt http BLOCKSTART PAGEIN SAMEFONT LOWERFONT 1 0 NOCAPS CONTAINSDIGITS 0 0 0 0 1 0 0 1 0 11 ://././.. 9 10 1 0 0 0 1
©2024 Ferrata ©2024 © ©2 ©20 ©202 BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 0 11 no 0 10 1 0 0 0 1
Published under published P Pu Pub Publ BLOCKSTART PAGEEND SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 11 - 1 10 1 0 0 0 1
Haematologica | haematologica H Ha Hae Haem BLOCKSTART PAGESTART SAMEFONT HIGHERFONT 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 0 0 no 0 10 0 0 1 0 0
2501 2501 2501 2 25 250 2501 BLOCKSTART PAGEIN NEWFONT HIGHERFONT 1 0 NOCAPS ALLDIGIT 0 0 0 0 1 0 0 0 0 0 no 0 10 0 0 0 0 0
ARTICLE -D-2-HG article A AR ART ARTI BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 0 0 1 0 0 0 0 0 0 0 --- 3 10 0 1 0 0 0
K. Hammon k. K K. K. K. BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 0 0 .. 2 2 0 1 0 0 0
of α-KG of o of of of BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 --/, 4 8 0 1 0 0 1
process termed process p pr pro proc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 "". 3 6 0 1 0 0 1
In some in I In In In BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 1 0 0 0 0 0 0 0 ,-- 3 9 0 1 0 0 1
with worse with w wi wit with BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 ,- 2 8 0 1 0 0 1
able prognostic able a ab abl able BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 .,, 3 10 0 1 0 0 1
the structural the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 --- 3 8 0 1 0 0 1
competition and competition c co com comp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 --, 3 8 0 1 0 0 1
such as such s su suc such BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 -.-- 4 8 0 1 0 0 1
also inhibits also a al als also BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 -() 3 9 0 1 0 0 1
5-methylcytosine hydroxylases, 5-methylcytosine 5 5- 5-m 5-me BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 0 0 -, 2 9 0 1 0 0 1
in the in i in in in BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 0 0 . 1 9 0 1 0 0 1
mutated AML mutated m mu mut muta BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 - 1 8 0 1 0 0 1
pression of pression p pr pre pres BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 0 no 0 9 0 1 0 0 1
in vitro in i in in in BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 0 0 - 1 9 0 1 0 0 1
ferentiation. 9 ferentiation. f fe fer fere BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 0 ., 2 9 0 1 0 0 1
expression of expression e ex exp expr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 no 0 8 0 1 0 0 1
leukemic transformation leukemic l le leu leuk BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 0 no 0 8 0 1 0 0 1
in cooperation in i in in in BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 0 0 ,. 2 9 0 1 0 0 1
contrast, it contrast, c co con cont BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 ,--, 4 9 0 1 0 0 1
its L-enantiomer, its i it its its BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 -, 2 8 0 1 0 0 1
in a in i in in in BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 0 0 -., 3 8 0 1 0 0 1
these data these t th the thes BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 --- 3 8 0 1 0 0 1
mulation dysregulate mulation m mu mul mula BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 0 , 1 8 0 1 0 0 1
turn disturbs turn t tu tur turn BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 .,- 3 8 0 1 0 0 1
dogenously produced dogenously d do dog doge BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 0 - 1 8 0 1 0 0 1
and differentiation and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 . 1 9 0 1 0 0 1
human T human h hu hum huma BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 ,,. 3 8 0 1 0 0 1
gene expression gene g ge gen gene BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 0 0 0 0 0 0 0 0 no 0 8 0 1 0 0 1
after D-2-HG after a af aft afte BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 --,-- 5 9 0 1 0 0 1
susceptibility between susceptibility s su sus susc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 . 1 8 0 1 0 0 1
The same the T Th The The BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 0 - 1 7 0 1 0 0 1
immunosuppression related immunosuppression i im imm immu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 0 --- 3 8 0 1 0 0 1
changes in changes c ch cha chan BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 0 0 - 1 8 0 1 0 0 1
macrophages. 14 macrophages. m ma mac macr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 0 . 1 2 0 1 0 0 1
Here, we here, H He Her Here BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 0 ,- 2 9 0 1 0 0 1
ant population ant a an ant ant BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 ,(). 4 9 0 1 0 0 1
In contrast in I In In In BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 1 0 0 0 0 0 0 0 , 1 9 0 1 0 0 1
we describe we w we we we BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 no 0 8 0 1 0 0 1
by D-2-HG by b by by by BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 --, 3 8 0 1 0 0 1
and reprogramming and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 . 1 8 0 1 0 0 1
suggest that suggest s su sug sugg BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 -- 2 8 0 1 0 0 1
by both by b by by by BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 no 0 8 0 1 0 0 1
of cellular of o of of of BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 . 1 3 0 1 0 0 1
Methods Methods methods M Me Met Meth BLOCKSTART PAGEIN NEWFONT HIGHERFONT 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 1 5 no 0 10 0 0 0 0 1
Primary cells primary P Pr Pri Prim BLOCKSTART PAGEIN NEWFONT LOWERFONT 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 1 5 no 0 5 0 0 0 0 1
Peripheral blood peripheral P Pe Per Peri BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 1 5 - 1 9 0 0 0 0 1
kapheresis products kapheresis k ka kap kaph BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 5 no 0 9 0 0 0 0 1
healthy donors healthy h he hea heal BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 5 / 1 10 0 0 0 0 1
Hypaque. Primary hypaque. H Hy Hyp Hypa BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 1 5 .- 2 9 0 0 0 0 1
ent centrifugation ent e en ent ent BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 5 / 1 9 0 0 0 0 1
of leukemia of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 5 , 1 9 0 0 0 0 1
had started had h ha had had BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 5 . 1 9 0 0 0 0 1
stem and stem s st ste stem BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 5 - 1 9 0 1 0 0 1
kapheresis products kapheresis k ka kap kaph BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 5 no 0 9 0 1 0 0 1
been stimulated been b be bee been BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 5 -. 2 9 0 1 0 0 1
The studies the T Th The The BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 1 5 - 1 8 0 1 0 0 1
laration of laration l la lar lara BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 5 . 1 10 0 1 0 0 1
to participation to t to to to BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 5 - 1 9 0 1 0 0 1
proved by proved p pr pro prov BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 5 no 0 9 0 1 0 0 1
Regensburg (permission regensburg R Re Reg Rege BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 1 5 (-,--,- 7 8 0 1 0 0 1
101-0240, 13-101-0238, 101-0240, 1 10 101 101- BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 1 5 -,--,--). 9 6 0 1 0 0 1
Monocyte isolation monocyte M Mo Mon Mono BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 1 6 no 0 7 0 0 0 0 1
Mononuclear cells mononuclear M Mo Mon Mono BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 1 6 no 0 9 0 0 0 0 1
leukapheresis, followed leukapheresis, l le leu leuk BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 6 , 1 9 0 0 0 0 1
over Ficoll/Hypaque. over o ov ove over BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 6 /.- 3 8 0 0 0 0 1
nuclear cells nuclear n nu nuc nucl BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 6 no 0 9 0 0 0 0 1
a J6M-E a a a a a BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 1 0 1 0 0 0 0 0 1 6 - 1 8 0 0 0 0 1
a JE-5 a a a a a BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 1 0 1 0 0 0 0 0 1 6 -,/ 3 9 0 0 0 0 1
in Hanks' in i in in in BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 1 6 '. 2 8 0 0 0 0 1
Elutriated monocytes elutriated E El Elu Elut BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 1 6 no 0 8 0 0 0 0 1
morphology and morphology m mo mor morp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 6 . 1 8 0 0 0 0 1
monocyte-derived human monocyte-derived m mo mon mono BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 6 -,- 3 8 0 0 0 0 1
cytes were cytes c cy cyt cyte BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 6 (, 2 9 0 0 0 0 1
Hanau, Germany) hanau, H Ha Han Hana BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 1 6 ,)/ 3 10 0 0 0 0 1
mL in ml m mL mL mL BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 6 no 0 8 0 0 0 0 1
AB group ab A AB AB AB BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 1 6 . 1 2 0 0 0 0 1
Dendritic cell dendritic D De Den Dend BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 1 8 no 0 4 0 0 0 0 1
Bone marrow-derived bone B Bo Bon Bone BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 1 1 0 0 0 0 0 1 8 -- 2 8 0 0 0 0 1
scribed previously scribed s sc scr scri BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 8 no 0 9 0 0 0 0 1
D-2-HG. D-2-HG. d-2-hg. D D- D-2 D-2- BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 1 8 --. 3 1 0 0 0 0 1
For the for F Fo For For BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 1 8 , 1 8 0 0 0 0 1
in RPMI in i in in in BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 1 8 ,- 2 8 0 0 0 0 1
mine (2 mine m mi min mine BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 8 (),(),(/), 10 9 0 0 0 0 1
interleukin 4 interleukin i in int inte BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 8 (/),- 5 8 0 0 0 0 1
colony-stimulating factor colony-stimulating c co col colo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 8 -(/) 4 9 0 0 0 0 1
1x10 6 1x10 1 1x 1x1 1x10 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 1 8 /- 2 10 0 0 0 0 1
a T25 a a a a a BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 1 0 1 0 0 0 0 0 1 8 .-- 3 8 0 0 0 0 1
once, immediately once, o on onc once BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 8 ,, 2 9 0 0 0 0 1
period of period p pe per peri BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 8 . 1 9 0 0 0 0 1
immature DC. immature i im imm imma BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 8 ., 2 8 0 0 0 0 1
supplemented with supplemented s su sup supp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 8 --(,),- 7 8 0 0 0 0 1
hibitor GNE140 hibitor h hi hib hibi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 8 (,)- 4 9 0 0 0 0 1
LDHA/B inhibitor ldha/b L LD LDH LDHA BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 1 8 /-(.,) 6 9 0 0 0 0 1
vitamin C vitamin v vi vit vita BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 8 (),. 4 9 0 0 0 0 1
by the by b by by by BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 8 /. 2 9 0 0 0 0 1
DC expressing dc D DC DC DC BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 1 8 - 1 8 0 0 0 0 1
transcribed RNA transcribed t tr tra tran BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 8 . 1 9 0 0 0 0 1
In brief, in I In In In BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 1 1 0 0 0 0 0 1 8 ,- 2 9 0 0 0 0 1
a HIS a a a a a BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 1 0 1 0 0 0 0 0 1 8 no 0 9 0 0 0 0 1
pGEM4Z-64A vector pgem4z-64a p pG pGE pGEM BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 1 8 -. 2 8 0 0 0 0 1
a QuikChange a a a a a BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 1 0 1 0 0 0 0 0 1 8 -,- 3 9 0 0 0 0 1
mutagenesis was mutagenesis m mu mut muta BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 8 - 1 8 0 0 0 0 1
sponsible for sponsible s sp spo spon BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 8 no 0 9 0 0 0 0 1
amino acid amino a am ami amin BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 8 (). 3 9 0 0 0 0 1
were used were w we wer were BLOCKEND PAGEEND SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 8 -. 2 8 0 0 0 0 1
Haematologica | haematologica H Ha Hae Haem BLOCKSTART PAGESTART NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 1 0 no 0 10 0 0 1 0 0
2502 2502 2502 2 25 250 2502 BLOCKSTART PAGEIN NEWFONT HIGHERFONT 1 0 NOCAPS ALLDIGIT 0 0 0 0 1 0 0 0 1 0 no 0 10 0 0 0 0 0
ARTICLE -D-2-HG article A AR ART ARTI BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 0 0 1 0 0 0 0 0 1 0 --- 3 10 0 1 0 0 0
K. Hammon k. K K. K. K. BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 1 0 .. 2 2 0 1 0 0 0
Acute myeloid acute A Ac Acu Acut BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 1 0 no 0 6 0 1 0 0 1
Primary AML primary P Pr Pri Prim BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 1 0 - 1 8 0 1 0 0 1
medium (GIBCO) medium m me med medi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 () 2 8 0 1 0 0 1
serum, 50 serum, s se ser seru BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 ,/-(,, 6 9 0 1 0 0 1
NJ, USA), nj, N NJ NJ, NJ, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 1 0 ,),/- 5 9 0 1 0 0 1
(Hospira, Lake (hospira, ( (H (Ho (Hos BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 0 (,,,)-- 7 9 0 1 0 0 1
HG (Sigma/Merck, hg H HG HG HG BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 1 0 (/,,), 6 8 0 1 0 0 1
C (Sigma/Merck) c C C C C BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 1 0 (/)(,, 6 8 0 1 0 0 1
Housten, TX, housten, H Ho Hou Hous BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 1 0 ,,),/ 5 10 0 1 0 0 1
mL for ml m mL mL mL BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 0 . 1 2 0 1 0 0 1
Cell numbers cell C Ce Cel Cell BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 1 1 no 0 4 0 0 0 0 1
Cell numbers, cell C Ce Cel Cell BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 1 1 , 1 10 0 0 0 0 1
either a either e ei eit eith BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 1 . 1 9 0 0 0 0 1
were resuspended were w we wer were BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 1 no 0 9 0 0 0 0 1
mixed with mixed m mi mix mixe BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 1 . 1 9 0 0 0 0 1
was transferred was w wa was was BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 1 no 0 9 0 0 0 0 1
of two of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 1 . 1 5 0 0 0 0 1
The CASY the T Th The The BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 1 1 (,- 3 9 0 0 0 0 1
ni Life ni n ni ni ni BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 1 ,,) 3 9 0 0 0 0 1
a cell a a a a a BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 1 0 1 0 0 0 0 0 1 1 -' 2 9 0 0 0 0 1
high-precision measuring high-precision h hi hig high BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 1 -.- 3 9 0 0 0 0 1
cording to cording c co cor cord BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 1 '. 2 7 0 0 0 0 1
Other methods other O Ot Oth Othe BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 1 3 no 0 2 0 0 0 0 1
The mixed the T Th The The BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 1 3 -- 2 9 0 0 0 0 1
scribed in scribed s sc scr scri BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 3 , 1 9 0 0 0 0 1
with detailed with w wi wit with BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 3 . 1 9 0 0 0 0 1
Online Supplementary online O On Onl Onli BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 1 3 no 0 9 0 0 0 0 1
on transmission on o on on on BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 3 , 1 9 0 0 0 0 1
for protein for f fo for for BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 3 , 1 10 0 0 0 0 1
gel electropheresis gel g ge gel gel BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 3 . 1 7 0 0 0 0 1
Oxygen consumption, oxygen O Ox Oxy Oxyg BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 1 4 , 1 8 0 0 0 0 1
Mitochondrial respiratory mitochondrial M Mi Mit Mito BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 1 4 no 0 9 0 0 0 0 1
high-resolution respirometry high-resolution h hi hig high BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 4 -. 2 9 0 0 0 0 1
Online-measurement of online-measurement O On Onl Onli BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 1 4 -- 2 9 0 0 0 0 1
mination of mination m mi min mina BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 4 no 0 10 0 0 0 0 1
detailed in detailed d de det deta BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 4 . 1 8 0 0 0 0 1
Flow cytometry, flow F Fl Flo Flow BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 4 ,,, 3 8 0 0 0 0 1
measurements measurements measurements m me mea meas BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 4 no 0 2 0 0 0 0 1
Details are details D De Det Deta BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 4 . 1 10 0 0 0 0 1
Colony-forming cell colony-forming C Co Col Colo BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 4 - 1 4 0 0 0 0 1
The colony-forming the T Th The The BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 4 - 1 10 0 0 0 0 1
previously 20 previously p pr pre prev BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 4 no 0 9 0 0 0 0 1
Methods. Methods. methods. M Me Met Meth BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 4 . 1 1 0 0 0 0 1
The Cancer the T Th The The BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 5 no 0 6 0 0 0 0 1
AML RNA aml A AM AML AML BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 2 5 ( 1 10 0 0 0 0 1
gene, displayed gene, g ge gen gene BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 5 , 1 10 0 0 0 0 1
reads) and reads) r re rea read BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 5 ) 1 10 0 0 0 0 1
from The from f fr fro from BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 5 (://. 5 10 0 0 0 0 1
gdc.cancer.gov). Normalized gdc.cancer.gov). g gd gdc gdc. BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 5 ..). 4 10 0 0 0 0 1
histocompatiblity complex histocompatiblity h hi his hist BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 5 () 2 10 0 1 0 0 1
genes (HLA-DP, genes g ge gen gene BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 5 (-,--)- 7 9 0 1 0 0 1
tivator (CIITA) tivator t ti tiv tiva BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 5 () 2 10 0 1 0 0 1
wild-type or wild-type w wi wil wild BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 5 -. 2 4 0 1 0 0 1
DNA methylation dna D DN DNA DNA BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 2 6 no 0 4 0 0 0 0 1
Methylation analysis methylation M Me Met Meth BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 2 6 . 1 10 0 0 0 0 1
Analyzed amplicons analyzed A An Ana Anal BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 6 no 0 9 0 0 0 0 1
Supplementary Table supplementary S Su Sup Supp BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 6 . 1 4 0 0 0 0 1
Statistical analysis statistical S St Sta Stat BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 6 no 0 3 0 0 0 0 1
The statistical the T Th The The BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 6 no 0 9 0 0 0 0 1
Prism, version prism, P Pr Pri Pris BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 6 ,(,,).- 7 9 0 0 0 0 1
en in en e en en en BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 6 . 1 9 0 0 0 0 1
groups were groups g gr gro grou BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 6 no 0 9 0 0 0 0 1
depending on depending d de dep depe BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 6 no 0 9 0 0 0 0 1
and variables and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 6 (,,-- 5 9 0 0 0 0 1
lis test, lis l li lis lis BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 6 ,--). 5 9 0 0 0 0 1
Differences were differences D Di Dif Diff BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 6 no 0 10 0 0 0 0 1
values of values v va val valu BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 6 .(*.,**.,***.). 15 8 0 0 0 0 1
Results Results results R Re Res Resu BLOCKSTART PAGEIN NEWFONT HIGHERFONT 1 0 INITCAP NODIGIT 0 1 1 0 0 0 0 0 2 8 no 0 10 0 0 0 0 1
D-2-hydroxyglutarate alters d-2-hydroxyglutarate D D- D-2 D-2- BLOCKSTART PAGEIN NEWFONT LOWERFONT 1 0 INITCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 8 -- 2 8 0 0 0 0 1
but not but b bu but but BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 8 no 0 5 0 0 0 0 1
High D-2-HG high H Hi Hig High BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 1 1 0 0 0 0 0 2 8 -- 2 9 0 0 0 0 1
known that known k kn kno know BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 8 --, 3 8 0 0 0 0 1
which may which w wh whi whic BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 8 -. 2 9 0 0 0 0 1
endogenous 2-HG endogenous e en end endo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 8 - 1 9 0 0 0 0 1
cells, T cells, c ce cel cell BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 8 ,,, 3 9 0 0 0 0 1
by liquid by b by by by BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 8 -. 2 8 0 0 0 0 1
cells, fibroblasts cells, c ce cel cell BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 8 ,(.., 5 9 0 0 0 0 1
macrophages) exhibited macrophages) m ma mac macr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 8 )- 2 9 0 0 0 0 1
compared to compared c co com comp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 8 , 1 9 0 0 0 0 1
levels could levels l le lev leve BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 8 no 0 9 0 0 0 0 1
D-2-HG, demonstrating d-2-hg, D D- D-2 D-2- BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 8 --, 3 9 0 0 0 0 1
active uptake active a ac act acti BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 8 (). 3 7 0 0 0 0 1
We, therefore, we, W We We, We, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 8 ,,-- 4 9 0 0 0 0 1
HG levels hg H HG HG HG BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 2 8 no 0 9 0 0 0 0 1
a 7-day a a a a a BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 1 0 1 0 0 0 0 0 2 8 --- 3 8 0 0 0 0 1
cyte-macrophage colony-stimulating cyte-macrophage c cy cyt cyte BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 8 --. 3 9 0 0 0 0 1
reported that reported r re rep repo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 8 --- 3 9 0 0 0 0 1
tiation. 15 tiation. t ti tia tiat BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 8 ., 2 10 0 0 0 0 1
monocytes into monocytes m mo mon mono BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 8 (/) 3 9 0 0 0 0 1
bone marrow bone b bo bon bone BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 2 8 -.-- 4 8 0 0 0 0 1
did not did d di did did BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 8 no 0 9 0 0 0 0 1
(Figure 1B), (figure ( (F (Fi (Fig BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 8 (), 3 9 0 0 0 0 1
technology were technology t te tec tech BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 8 -- 2 9 0 0 0 0 1
rived DC rived r ri riv rive BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 8 --( 3 9 0 0 0 0 1
S1A). Interestingly, s1a). S S1 S1A S1A) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 8 )., 3 9 0 0 0 0 1
changes in changes c ch cha chan BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 2 8 no 0 9 0 0 0 0 1
numbers of numbers n nu num numb BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 2 8 no 0 9 0 0 0 0 1
D-2-HG-treated human d-2-hg-treated D D- D-2 D-2- BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 8 ---- 4 8 0 0 0 0 1
trols (Figure trols t tr tro trol BLOCKEND PAGEEND SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 8 (,). 4 9 0 0 0 0 1
Haematologica | haematologica H Ha Hae Haem BLOCKSTART PAGESTART NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 2 0 no 0 10 0 0 1 0 0
2503 2503 2503 2 25 250 2503 BLOCKSTART PAGEIN NEWFONT HIGHERFONT 1 0 NOCAPS ALLDIGIT 0 0 0 0 1 0 0 0 2 0 no 0 10 0 0 0 0 0
ARTICLE -D-2-HG article A AR ART ARTI BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 0 0 1 0 0 0 0 0 2 0 --- 3 10 1 1 0 0 0
K. Hammon k. K K. K. K. BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 2 0 .. 2 2 1 1 0 0 0
Figure 1. figure F Fi Fig Figu BLOCKSTART PAGEIN SAMEFONT LOWERFONT 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 0 .--.()-(-) 10 9 1 1 0 0 1
were analyzed were w we wer were BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 (),( 4 9 1 1 0 0 1
days of days d da day days BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 ,),(),()() 10 9 1 1 0 0 1
or without or o or or or BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 --().()()()() 13 9 1 1 0 0 1
after 7 after a af aft afte BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 ()().()- 8 9 1 1 0 0 1
ence or ence e en enc ence BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 0 --.,. 5 9 1 1 0 0 1
ten cells ten t te ten ten BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 (--).()() 9 9 1 1 0 0 1
and monocyte-derived and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 ---()().() 10 9 1 1 0 0 1
were cultured were w we wer were BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 --.-()-/-() 11 9 1 1 0 0 1
by flow by b by by by BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 (-,--).() 9 9 1 1 0 0 1
Representative histogram representative R Re Rep Repr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 0 -()-/-().()-- 13 9 1 1 0 0 1
pression on pression p pr pre pres BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 0 ()() 4 9 1 1 0 0 1
(N=46) of (n=46) ( (N (N= (N=4 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 0 ()(--).()(-[]), 15 9 1 1 0 0 1
interleukin-10 [N=6], interleukin-10 i in int inte BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 0 -[],[]-[])- 11 9 1 1 0 0 1
assay (ELISA) assay a as ass assa BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 ()(/).()() 10 9 1 1 0 0 1
stimulated with stimulated s st sti stim BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 ()--. 5 9 1 1 0 0 1
mixed lymphocyte mixed m mi mix mixe BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 ,-().()-() 10 10 1 1 0 0 1
analyzed in analyzed a an ana anal BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 . 1 9 1 1 0 0 1
independent experiments independent i in ind inde BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 .-- 3 9 1 1 0 0 1
test was test t te tes test BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 .---.. 6 9 1 1 0 0 1
statistically significant statistically s st sta stat BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 (*.,***.,***.).:;/:;:; 22 9 1 1 0 0 1
MFI: mean mfi: M MF MFI MFI: BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 2 0 :;:;:;:. 8 7 1 1 0 0 1
A A a A A A A BLOCKSTART PAGEIN SAMEFONT HIGHERFONT 1 0 ALLCAP NODIGIT 1 0 1 0 0 0 0 0 3 11 no 0 10 1 1 0 0 1
D D d D D D D BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 3 11 no 0 10 0 0 0 0 1
G G g G G G G BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 3 11 no 0 10 0 0 0 0 1
H H h H H H H BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 3 11 no 0 10 0 0 0 0 1
I I i I I I I BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 3 11 no 0 10 0 0 0 0 1
E E e E E E E BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 3 11 no 0 10 0 0 0 0 1
F F f F F F F BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 3 11 no 0 10 0 0 0 0 1
B B b B B B B BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 3 11 no 0 10 1 1 0 0 1
C C c C C C C BLOCKEND PAGEEND SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 3 11 no 0 10 1 1 0 0 1
Haematologica | haematologica H Ha Hae Haem BLOCKSTART PAGESTART NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 3 0 no 0 10 0 0 1 0 0
2504 2504 2504 2 25 250 2504 BLOCKSTART PAGEIN NEWFONT HIGHERFONT 1 0 NOCAPS ALLDIGIT 0 0 0 0 1 0 0 0 3 0 no 0 10 0 0 0 0 0
ARTICLE -D-2-HG article A AR ART ARTI BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 0 0 1 0 0 0 0 0 3 0 --- 3 10 0 1 0 0 0
K. Hammon k. K K. K. K. BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 3 0 .. 2 2 0 1 0 0 0
field microscopic field f fi fie fiel BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 3 0 - 1 9 0 1 0 0 1
DC revealed dc D DC DC DC BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 3 0 no 0 9 0 1 0 0 1
treated with treated t tr tre trea BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 --(- 4 8 0 1 0 0 1
plementary Figure plementary p pl ple plem BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 0 ). 2 3 0 1 0 0 1
To assess to T To To To BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 0 -- 2 9 0 1 0 0 1
progenitor cells, progenitor p pr pro prog BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 ,-- 3 8 0 1 0 0 1
differentiation of differentiation d di dif diff BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 no 0 9 0 1 0 0 1
progenitor cells progenitor p pr pro prog BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 -(). 4 9 0 1 0 0 1
plating defined plating p pl pla plat BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 0 ,- 2 10 0 1 0 0 1
and colony-forming and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 -(). 4 8 0 1 0 0 1
D-2-HG treatment d-2-hg D D- D-2 D-2- BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 0 --- 3 8 0 1 0 0 1
ber of ber b be ber ber BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 0 (... 4 9 0 1 0 0 1
CFC/100 CD34 cfc/100 C CF CFC CFC/ BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 0 /;.) 4 9 0 1 0 0 1
size (Online size s si siz size BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 (,).,-- 7 9 0 1 0 0 1
resulted in resulted r re res resu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 --- 3 8 0 1 0 0 1
rophage myeloid rophage r ro rop roph BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 0 (...), 6 9 0 1 0 0 1
proportion of proportion p pr pro prop BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 -(...) 6 9 0 1 0 0 1
(Online Supplementary (online ( (O (On (Onl BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 0 (,). 4 6 0 1 0 0 1
D-2-hydroxyglutarate limits d-2-hydroxyglutarate D D- D-2 D-2- BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 1 0 INITCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 2 -- 2 8 0 0 0 0 1
human but human h hu hum huma BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 2 - 1 8 0 0 0 0 1
stimulation stimulation stimulation s st sti stim BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 2 no 0 1 0 0 0 0 1
To further to T To To To BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 2 -- 2 8 0 0 0 0 1
murine DC murine m mu mur muri BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 2 ,- 2 9 0 0 0 0 1
sion of sion s si sio sion BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 2 - 1 8 0 0 0 0 1
equivalent in equivalent e eq equ equi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 2 . 1 9 0 0 0 0 1
of HLA-DP of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 2 - 1 8 0 0 0 0 1
was significantly was w wa was was BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 2 ---(.) 6 9 0 0 0 0 1
(Figure 1D, (figure ( (F (Fi (Fig BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 2 (,)., 5 9 0 0 0 0 1
of the of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 2 --/- 4 9 0 0 0 0 1
on murine on o on on on BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 2 -(.)(, 6 8 0 0 0 0 1
E). Based e). E E) E). E). BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 3 2 ). 2 9 0 0 0 0 1
other MHC other o ot oth othe BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 2 . 1 8 0 0 0 0 1
the findings the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 2 -,- 3 8 0 0 0 0 1
-DR was -dr - -D -DR -DR BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 3 2 --- 3 9 0 0 0 0 1
treatment (Figure treatment t tr tre trea BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 2 (,). 4 8 0 0 0 0 1
Surface expression surface S Su Sur Surf BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 2 no 0 9 0 0 0 0 1
during D-2-HG during d du dur duri BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 2 -- 2 8 0 0 0 0 1
statistical significance statistical s st sta stat BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 2 (). 3 9 0 0 0 0 1
Furthermore, D-2-HG furthermore, F Fu Fur Furt BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 2 ,-- 3 8 0 0 0 0 1
markers such markers m ma mar mark BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 2 -( 2 8 0 0 0 0 1
Figure S1G, figure F Fi Fig Figu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 2 ,).,- 5 9 0 0 0 0 1
lated during lated l la lat late BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 2 , 1 10 0 0 0 0 1
the presence the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 2 --(). 5 9 0 0 0 0 1
Next, we next, N Ne Nex Next BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 2 ,--- 4 9 0 0 0 0 1
DC. DC dc. D DC DC. DC. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 3 2 . 1 9 0 0 0 0 1
cytokine levels cytokine c cy cyt cyto BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 2 . 1 8 0 0 0 0 1
Similar to similar S Si Sim Simi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 2 --- 3 9 0 0 0 0 1
HG, 22 hg, H HG HG, HG, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 3 2 ,- 2 9 0 0 0 0 1
by D-2-HG by b by by by BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 2 --(,.),- 8 8 0 0 0 0 1
kin-10 secretion kin-10 k ki kin kin- BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 2 -. 2 9 0 0 0 0 1
Tumor necrosis tumor T Tu Tum Tumo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 2 - 1 9 0 0 0 0 1
influenced by influenced i in inf infl BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 2 --()., 6 9 0 0 0 0 1
in line in i in in in BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 3 2 - 1 9 0 0 0 0 1
expression, D-2-HG-treated expression, e ex exp expr BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 2 ,---- 5 8 0 0 0 0 1
lators in lators l la lat lato BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 6 no 0 9 0 1 0 0 1
T cells, t T T T T BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 3 6 ,- 2 10 0 1 0 0 1
(70% that (70% ( (7 (70 (70% BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 6 ()-( 4 9 0 1 0 0 1
approximately 45%) approximately a ap app appr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 6 )(,).,-- 8 9 0 1 0 0 1
the morphology the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 6 , 1 8 0 1 0 0 1
with an with w wi wit with BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 6 . 1 7 0 1 0 0 1
D-2-hydroxyglutarate reprograms d-2-hydroxyglutarate D D- D-2 D-2- BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 1 0 INITCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 6 -- 2 7 0 0 0 0 1
demethylation during demethylation d de dem deme BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 6 no 0 7 0 0 0 0 1
Metabolic processes metabolic M Me Met Meta BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 6 - 1 9 0 0 0 0 1
tiation of tiation t ti tia tiat BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 6 no 0 8 0 0 0 0 1
during DC during d du dur duri BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 6 . 1 8 0 0 0 0 1
the number the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 6 no 0 8 0 0 0 0 1
monocytes, whereas monocytes, m mo mon mono BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 6 ,() 3 8 0 0 0 0 1
reduced when reduced r re red redu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 6 . 1 8 0 0 0 0 1
therefore hypothesized therefore t th the ther BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 6 --- 3 8 0 0 0 0 1
tiation and tiation t ti tia tiat BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 6 ., 2 9 0 0 0 0 1
we measured we w we we we BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 6 ,,, 3 8 0 0 0 0 1
and lactate and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 6 - 1 9 0 0 0 0 1
ed in ed e ed ed ed BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 1 0 0 0 0 0 0 3 6 --. 3 8 0 0 0 0 1
D-2-HG resulted d-2-hg D D- D-2 D-2- BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 6 -- 2 8 0 0 0 0 1
significantly lower significantly s si sig sign BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 6 (...) 5 9 0 0 0 0 1
higher lactate higher h hi hig high BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 6 (...)- 6 9 0 0 0 0 1
ture supernatants ture t tu tur ture BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 6 ().,-- 6 9 0 0 0 0 1
to the to t to to to BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 6 no 0 9 0 0 0 0 1
cells in cells c ce cel cell BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 6 .,--- 5 9 0 0 0 0 1
DC produced dc D DC DC DC BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 3 6 (.. 3 9 0 0 0 0 1
392.5 μM) 392.5 3 39 392 392. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 6 .)(. 4 8 0 0 0 0 1
vs. 606.6 vs. v vs vs. vs. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 6 ..)(). 6 8 0 0 0 0 1
amino acids amino a am ami amin BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 6 --( 3 8 0 0 0 0 1
Supplementary Figure supplementary S Su Sup Supp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 6 ). 2 4 0 0 0 0 1
In line in I In In In BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 1 1 0 0 0 0 0 3 6 , 1 10 0 0 0 0 1
A (LDHA) a A A A A BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 1 0 1 0 0 0 0 0 3 6 ()(,).- 7 9 0 0 0 0 1
ally regulated ally a al all ally BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 3 6 no 0 9 0 0 0 0 1
presence of presence p pr pre pres BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 6 -- 2 8 0 0 0 0 1
upregulated on upregulated u up upr upre BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 6 (,). 4 9 0 0 0 0 1
a significant a a a a a BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 1 0 1 0 0 0 0 0 3 6 -- 2 9 0 0 0 0 1
ence of ence e en enc ence BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 6 --(). 5 9 0 0 0 0 1
the L-enantiomer the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 6 ---.-- 6 8 0 0 0 0 1
culture, acidification culture, c cu cul cult BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 6 , 1 9 0 0 0 0 1
supplemented with supplemented s su sup supp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 6 ()., 4 9 0 0 0 0 1
D-2-HG and d-2-hg D D- D-2 D-2- BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 6 ---- 4 7 0 0 0 0 1
(Online Supplementary (online ( (O (On (Onl BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 6 (). 3 5 0 0 0 0 1
As D-2-HG as A As As As BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 6 --, 3 8 0 0 0 0 1
expressing mutated expressing e ex exp expr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 6 no 0 8 0 0 0 0 1
transfection by transfection t tr tra tran BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 6 -. 2 8 0 0 0 0 1
consumption (ROUTINE consumption c co con cons BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 6 ()- 3 8 0 0 0 0 1
tated IDH1 tated t ta tat tate BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 6 no 0 8 0 0 0 0 1
expressing wild-type expressing e ex exp expr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 6 -( 2 8 0 0 0 0 1
Figure S2C). figure F Fi Fig Figu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 6 ).-- 4 8 0 0 0 0 1
endogenously or endogenously e en end endo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 6 ,-- 3 8 0 0 0 0 1
HG-treated DC hg-treated H HG HG- HG-t BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 3 6 --. 3 8 0 0 0 0 1
respiration was respiration r re res resp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 6 no 0 9 0 0 0 0 1
with D-2-HG with w wi wit with BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 6 --(.)(). 8 8 0 0 0 0 1
Higher mitochondrial higher H Hi Hig High BLOCKEND PAGEEND SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 6 - 1 9 0 0 0 0 1
Haematologica | haematologica H Ha Hae Haem BLOCKSTART PAGESTART NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 4 0 no 0 10 0 0 1 0 0
2505 2505 2505 2 25 250 2505 BLOCKSTART PAGEIN NEWFONT HIGHERFONT 1 0 NOCAPS ALLDIGIT 0 0 0 0 1 0 0 0 4 0 no 0 10 0 0 0 0 0
ARTICLE -D-2-HG article A AR ART ARTI BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 0 0 1 0 0 0 0 0 4 0 --- 3 10 1 1 0 0 0
K. Hammon k. K K. K. K. BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 4 0 .. 2 2 1 1 0 0 0
Figure 2. figure F Fi Fig Figu BLOCKSTART PAGEIN SAMEFONT LOWERFONT 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 4 1 .--.() 6 9 1 1 0 0 1
supernatants of supernatants s su sup supe BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 1 (,)--(--) 9 9 1 1 0 0 1
culture. Dashed culture. c cu cul cult BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 1 ..()() 6 9 1 1 0 0 1
and MYC and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 1 --.(,) 6 9 1 1 0 0 1
of actin-normalized of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 1 -()().() 8 9 1 1 0 0 1
of 20 of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 1 ----;- 6 9 1 1 0 0 1
pendent experiments pendent p pe pen pend BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 1 .()-. 5 8 1 1 0 0 1
showing active showing s sh sho show BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 1 -(,,,). 7 9 1 1 0 0 1
Data represent data D Da Dat Data BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 4 1 .(- 3 9 1 1 0 0 1
and 5-hydroxymethylcytosine, and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 1 -,)() 5 9 1 1 0 0 1
is indicated is i is is is BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 1 (:,:). 6 10 1 1 0 0 1
A A a A A A A BLOCKSTART PAGEIN SAMEFONT HIGHERFONT 1 0 ALLCAP NODIGIT 1 0 1 0 0 0 0 0 4 11 no 0 10 1 1 0 0 1
B B b B B B B BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 4 11 no 0 10 0 0 0 0 1
C C c C C C C BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 4 11 no 0 10 0 0 0 0 1
D D d D D D D BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 4 11 no 0 10 0 0 0 0 1
E E e E E E E BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 4 11 no 0 10 0 0 0 0 1
F F f F F F F BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 4 11 no 0 10 0 0 0 0 1
Continued on continued C Co Con Cont BLOCKSTART PAGEEND NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 4 11 . 1 10 0 0 1 1 0
Haematologica | haematologica H Ha Hae Haem BLOCKSTART PAGESTART SAMEFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 4 0 no 0 10 0 0 1 0 0
2506 2506 2506 2 25 250 2506 BLOCKSTART PAGEIN NEWFONT HIGHERFONT 1 0 NOCAPS ALLDIGIT 0 0 0 0 1 0 0 0 4 0 no 0 10 0 0 0 0 0
ARTICLE -D-2-HG article A AR ART ARTI BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 0 0 1 0 0 0 0 0 4 0 --- 3 10 0 1 0 0 0
K. Hammon k. K K. K. K. BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 4 0 .. 2 2 0 1 0 0 0
tion of tion t ti tio tion BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 0 ., 2 8 0 0 0 0 1
change in change c ch cha chan BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 no 0 8 0 0 0 0 1
observed (Online observed o ob obs obse BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 ()., 4 8 0 0 0 0 1
D-2-HG treatment d-2-hg D D- D-2 D-2- BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 0 -- 2 8 0 0 0 0 1
activity of activity a ac act acti BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 . 1 2 0 0 0 0 1
Mitochondria are mitochondria M Mi Mit Mito BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 4 0 , 1 9 0 0 0 0 1
generate acetyl-CoA generate g ge gen gene BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 --- 3 8 0 0 0 0 1
duction used duction d du duc duct BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 0 no 0 9 0 0 0 0 1
and DNA, and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 ,. 2 9 0 0 0 0 1
differentiation of differentiation d di dif diff BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 no 0 9 0 0 0 0 1
the expression the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 .-- 3 9 0 0 0 0 1
enzymes of enzymes e en enz enzy BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 --- 3 8 0 0 0 0 1
cytosine hydroxylases. cytosine c cy cyt cyto BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 0 . 1 9 0 0 0 0 1
of D-2-HG of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 -- 2 8 0 0 0 0 1
in the in i in in in BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 4 0 , 1 9 0 0 0 0 1
known to known k kn kno know BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 . 1 10 0 0 0 0 1
demethylation of demethylation d de dem deme BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 0 --- 3 8 0 0 0 0 1
become demethylated become b be bec beco BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 , 1 8 0 0 0 0 1
CLEC10A, CCL13, clec10a, C CL CLE CLEC BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 0 ,,(). 5 8 0 0 0 0 1
accelerated demethylation accelerated a ac acc acce BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 no 0 9 0 0 0 0 1
counteracted the counteracted c co cou coun BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 -- 2 9 0 0 0 0 1
and ROUTINE and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 (, 2 8 0 0 0 0 1
Figure S2F). figure F Fi Fig Figu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 4 0 )., 3 9 0 0 0 0 1
that were that t th tha that BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 () 2 9 0 0 0 0 1
was also was w wa was was BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 --( 3 8 0 0 0 0 1
Figure S2G, figure F Fi Fig Figu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 4 0 ,).-- 5 9 0 0 0 0 1
demethylation during demethylation d de dem deme BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 0 , 1 9 0 0 0 0 1
may contribute may m ma may may BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 1 0 0 4 0 . 1 8 0 0 0 0 1
Modulating dendritic modulating M Mo Mod Modu BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 4 3 no 0 8 0 0 0 0 1
lactate dehydrogenase lactate l la lac lact BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 3 no 0 5 0 0 0 0 1
Culture medium culture C Cu Cul Cult BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 4 3 ---- 4 8 0 0 0 0 1
HG exhibited hg H HG HG HG BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 4 3 no 0 8 0 0 0 0 1
lactate levels lactate l la lac lact BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 3 . 1 9 0 0 0 0 1
was elevated was w wa was was BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 3 no 0 8 0 0 0 0 1
both enantiomers both b bo bot both BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 3 ()- 3 8 0 0 0 0 1
ered HLA-DR ered e er ere ered BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 3 --(,). 6 8 0 0 0 0 1
To clarify to T To To To BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 4 3 no 0 10 0 0 0 0 1
MHC class mhc M MH MHC MHC BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 4 3 , 1 9 0 0 0 0 1
10 mM 10 1 10 10 10 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 4 3 ,- 2 9 0 0 0 0 1
HLA-DP expression hla-dp H HL HLA HLA- BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 4 3 -(,) 4 9 0 0 0 0 1
extracellular pH extracellular e ex ext extr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 3 no 0 9 0 0 0 0 1
2-HG or 2-hg 2 2- 2-H 2-HG BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 3 -(). 4 5 0 0 0 0 1
As vitamin as A As As As BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 4 3 --- 3 8 0 0 0 0 1
in demethylation in i in in in BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 4 3 , 1 9 0 0 0 0 1
whether vitamin whether w wh whe whet BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 3 no 0 8 0 0 0 0 1
metabolic phenotype metabolic m me met meta BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 5 . 1 8 0 0 0 0 1
C reduced c C C C C BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 5 5 - 1 9 0 0 0 0 1
DC cultures dc D DC DC DC BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 5 5 () 2 9 0 0 0 0 1
levels in levels l le lev leve BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 5 no 0 9 0 0 0 0 1
DC control dc D DC DC DC BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 5 5 ()., 4 9 0 0 0 0 1
was partially was w wa was was BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 5 (-). 4 6 0 0 0 0 1
Next we next N Ne Nex Next BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 5 5 no 0 8 0 0 0 0 1
D-2-HG by d-2-hg D D- D-2 D-2- BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 5 -- 2 9 0 0 0 0 1
GNE140 (1 gne140 G GN GNE GNE1 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 5 (). 3 8 0 0 0 0 1
vitamin C vitamin v vi vit vita BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 5 no 0 9 0 0 0 0 1
levels (Figure levels l le lev leve BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 5 (). 3 9 0 0 0 0 1
vitamin C vitamin v vi vit vita BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 5 ,--(- 5 8 0 0 0 0 1
line Supplementary line l li lin line BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 5 ). 2 9 0 0 0 0 1
increased the increased i in inc incr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 5 ---, 4 9 0 0 0 0 1
CD1a and cd1a C CD CD1 CD1a BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 5 - 1 8 0 0 0 0 1
C and c C C C C BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 5 5 no 0 9 0 0 0 0 1
control levels control c co con cont BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 5 -()()( 6 9 0 0 0 0 1
3H-K). HLA-DP 3h-k). 3 3H 3H- 3H-K BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 5 -).-- 5 8 0 0 0 0 1
no longer no n no no no BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 5 , 1 10 0 0 0 0 1
levels. Similar levels. l le lev leve BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 5 .- 2 9 0 0 0 0 1
LDHA/B inhibitor ldha/b L LD LDH LDHA BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 5 5 /-(.)- 6 9 0 0 0 0 1
tamin C. tamin t ta tam tami BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 5 .- 2 9 0 0 0 0 1
partially reverted partially p pa par part BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 5 (- 2 9 0 0 0 0 1
mentary Figure mentary m me men ment BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 5 -)., 4 9 0 0 0 0 1
strengthen the strengthen s st str stre BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 5 no 0 9 0 0 0 0 1
improvement of improvement i im imp impr BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 5 . 1 8 0 0 0 0 1
Exogenous D-2-hydroxyglutarate exogenous E Ex Exo Exog BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 5 7 -- 2 8 0 0 0 0 1
regulates lactate regulates r re reg regu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 7 no 0 9 0 0 0 0 1
in primary in i in in in BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 5 7 - 1 8 0 0 0 0 1
As D-2-HG as A As As As BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 5 7 --- 3 8 0 0 0 0 1
cyte-derived DC, cyte-derived c cy cyt cyte BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 7 -, 2 9 0 0 0 0 1
primary AML primary p pr pri prim BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 7 .,, 3 8 0 0 0 0 1
and glucose and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 7 no 0 9 0 0 0 0 1
wild-type AML wild-type w wi wil wild BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 7 ---. 4 9 0 0 0 0 1
D-2-HG significantly d-2-hg D D- D-2 D-2- BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 7 --- 3 9 0 0 0 0 1
creased lactate creased c cr cre crea BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 7 (... 4 10 0 0 0 0 1
mM), in mm), m mM mM) mM), BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 7 ),(). 5 9 0 0 0 0 1
Induction of induction I In Ind Indu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 5 7 no 0 9 0 0 0 0 1
was not was w wa was was BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 7 , 1 9 0 0 0 0 1
the already the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 7 - 1 9 0 0 0 0 1
tate of tate t ta tat tate BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 1 0 0 0 0 0 0 5 7 ., 2 9 0 0 0 0 1
observed no observed o ob obs obse BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 7 (, 2 9 0 0 0 0 1
Online Supplementary online O On Onl Onli BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 5 7 ).-- 4 9 0 0 0 0 1
on DC on o on on on BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 7 no 0 8 0 0 0 0 1
Online Supplementary online O On Onl Onli BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 5 7 ; 1 9 0 0 0 0 1
detected by detected d de det dete BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 10 -/(-). 6 9 0 1 0 0 1
of representative of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 10 () 2 9 0 1 0 0 1
methylation ratios methylation m me met meth BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 10 .(-) 4 9 0 1 0 0 1
represent individual represent r re rep repr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 10 .-- 3 9 0 1 0 0 1
parisons, the parisons, p pa par pari BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 10 ,-;()--.. 9 9 0 1 0 0 1
was considered was w wa was was BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 10 (*.,***.,***.)./:;:;:;:- 24 9 0 1 0 0 1
tic acid; tic t ti tic tic BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 10 ;:;:;-:-;:;:;:;: 16 10 0 1 0 0 1
dendritic cells; dendritic d de den dend BLOCKEND PAGEEND SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 10 ;:;:;:-;:-. 11 7 0 1 0 0 1
Haematologica | haematologica H Ha Hae Haem BLOCKSTART PAGESTART SAMEFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 5 0 no 0 10 0 0 1 0 0
2507 2507 2507 2 25 250 2507 BLOCKSTART PAGEIN NEWFONT HIGHERFONT 1 0 NOCAPS ALLDIGIT 0 0 0 0 1 0 0 0 5 0 no 0 10 0 0 0 0 0
ARTICLE -D-2-HG article A AR ART ARTI BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 0 0 1 0 0 0 0 0 5 0 --- 3 10 0 0 0 0 0
K. Hammon k. K K. K. K. BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 5 0 .. 2 2 0 0 0 0 0
normalized to normalized n no nor norm BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 0 (- 2 8 1 1 0 0 1
um concentration). um u um um um BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 0 ). 2 9 1 1 0 0 1
affected by affected a af aff affe BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 0 --(,)., 7 9 1 1 0 0 1
levels in levels l le lev leve BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 0 -- 2 9 1 1 0 0 1
7 days 7 7 7 7 7 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 5 0 (). 3 10 1 1 0 0 1
has been has h ha has has BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 2 no 0 10 1 1 0 0 1
predominantly at predominantly p pr pre pred BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 2 , 1 9 1 1 0 0 1
analyzed HLA-DP analyzed a an ana anal BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 2 -(,)- 5 8 1 1 0 0 1
(Online Supplementary (online ( (O (On (Onl BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 2 (,) 3 10 1 1 0 0 1
level in level l le lev leve BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 2 ., 2 9 1 1 0 0 1
Figure 3. figure F Fi Fig Figu BLOCKSTART PAGEIN NEWFONT LOWERFONT 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 5 3 .---.() 7 9 1 1 0 0 1
plot showing plot p pl plo plot BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 3 ()--(--)--- 11 9 1 1 0 0 1
droxyglutarate (L-2-HG) droxyglutarate d dr dro drox BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 3 (--)(),(,)- 11 10 1 1 0 0 1
genase inhibitor genase g ge gen gena BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 3 (,),-(.,- 9 9 1 1 0 0 1
ed on ed e ed ed ed BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 1 0 0 0 0 0 0 5 3 ).()-()---,-- 13 9 1 1 0 0 1
acid was acid a ac aci acid BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 3 .(-)--- 7 9 1 1 0 0 1
inhibitors (1 inhibitors i in inh inhi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 3 (,)..()- 8 9 1 1 0 0 1
DP (N=5), dp D DP DP DP BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 5 3 (),()-(),()()()-()-- 20 9 1 1 0 0 1
(1 mM (1 ( (1 (1 (1 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 3 (,). 4 9 1 1 0 0 1
in independent in i in in in BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 5 3 .-,- 4 9 1 1 0 0 1
ance and ance a an anc ance BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 3 -,..(*., 8 9 1 1 0 0 1
**P<0.01, ***P<0.001, **p<0.01, * ** **P **P< BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 3 **.,***.,****.).:;:. 20 6 1 1 0 0 1
A A a A A A A BLOCKSTART PAGEIN SAMEFONT HIGHERFONT 1 0 ALLCAP NODIGIT 1 0 1 0 0 0 0 0 6 11 no 0 10 1 1 0 0 1
D D d D D D D BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 6 11 no 0 10 0 0 0 0 1
H H h H H H H BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 6 11 no 0 10 0 0 0 0 1
I I i I I I I BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 6 11 no 0 10 0 0 0 0 1
J J j J J J J BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 6 11 no 0 10 0 0 0 0 1
K K k K K K K BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 6 11 no 0 10 0 0 0 0 1
E E e E E E E BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 6 11 no 0 10 0 0 0 0 1
G G g G G G G BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 6 11 no 0 10 0 0 0 0 1
F F f F F F F BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 6 11 no 0 10 0 0 0 0 1
B B b B B B B BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 6 11 no 0 10 1 1 0 0 1
C C c C C C C BLOCKEND PAGEEND SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 6 11 no 0 10 1 1 0 0 1
Haematologica | haematologica H Ha Hae Haem BLOCKSTART PAGESTART NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 6 0 no 0 10 0 0 1 0 0
2508 2508 2508 2 25 250 2508 BLOCKSTART PAGEIN NEWFONT HIGHERFONT 1 0 NOCAPS ALLDIGIT 0 0 0 0 1 0 0 0 6 0 no 0 10 0 0 0 0 0
ARTICLE -D-2-HG article A AR ART ARTI BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 0 0 1 0 0 0 0 0 6 0 --- 3 10 0 0 0 0 0
K. Hammon k. K K. K. K. BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 6 0 .. 2 2 0 0 0 0 0
was significantly was w wa was was BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 0 - 1 9 1 1 0 0 1
trations above trations t tr tra trat BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 0 no 0 9 1 1 0 0 1
levels, irrespectively levels, l le lev leve BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 0 ,-- 3 9 1 1 0 0 1
time (median time t ti tim time BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 0 (-.,-,.,, 9 10 1 1 0 0 1
respectively) (Figure respectively) r re res resp BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 0 )(, 3 9 1 1 0 0 1
S4C). Additionally s4c). S S4 S4C S4C) BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 1 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 2 ). 2 10 1 1 0 0 1
correlated with correlated c co cor corr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 2 -(-.,.) 7 9 1 1 0 0 1
HLA-DR (r hla-dr H HL HLA HLA- BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 6 2 -(-.,.)(, 9 9 1 1 0 0 1
Online Supplementary online O On Onl Onli BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 INITCAP NODIGIT 0 0 0 0 0 0 0 0 6 2 ). 2 5 1 1 0 0 1
In summary, in I In In In BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 1 INITCAP NODIGIT 0 1 1 0 0 0 0 0 6 2 ,--- 4 9 1 1 0 0 1
Figure 4. figure F Fi Fig Figu BLOCKSTART PAGEIN NEWFONT LOWERFONT 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 6 3 .-- 3 9 1 1 0 0 1
MHC class mhc M MH MHC MHC BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 6 3 .()() 5 9 1 1 0 0 1
cells cultured cells c ce cel cell BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 3 --(--)(). 9 9 1 1 0 0 1
the respective the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 3 .()() 5 9 1 1 0 0 1
(C) viability (c) ( (C (C) (C) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 6 3 ()()--.()(,;, 13 9 1 1 0 0 1
N=9) of n=9) N N= N=9 N=9) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 3 )()---.()-- 11 9 1 1 0 0 1
sion of sion s si sio sion BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 3 -.() 4 9 1 1 0 0 1
Correlations of correlations C Co Cor Corr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 6 3 -.-- 4 9 1 1 0 0 1
black, samples black, b bl bla blac BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 3 ,--; 4 9 1 1 0 0 1
dots (<10 dots d do dot dots BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 3 (,).--.. 8 8 1 1 0 0 1
was considered was w wa was was BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 3 (*.,**.).()./:- 15 9 1 1 0 0 1
out; Ala: out; o ou out out; BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 3 ;:;:;:;:;:;-:-;: 16 10 1 1 0 0 1
glutamic acid; glutamic g gl glu glut BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 3 ;:;:;:. 7 5 1 1 0 0 1
A A a A A A A BLOCKSTART PAGEIN SAMEFONT HIGHERFONT 1 0 ALLCAP NODIGIT 1 0 1 0 0 0 0 0 6 11 no 0 10 1 1 0 0 1
B B b B B B B BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 6 11 no 0 10 0 0 0 0 1
C C c C C C C BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 6 11 no 0 10 0 0 0 0 1
D D d D D D D BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 6 11 no 0 10 0 0 0 0 1
E E e E E E E BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 6 11 no 0 10 0 0 0 0 1
F F f F F F F BLOCKEND PAGEEND SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 6 11 no 0 10 0 0 0 0 1
Haematologica | haematologica H Ha Hae Haem BLOCKSTART PAGESTART NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 6 0 no 0 10 0 0 1 0 0
2509 2509 2509 2 25 250 2509 BLOCKSTART PAGEIN NEWFONT HIGHERFONT 1 0 NOCAPS ALLDIGIT 0 0 0 0 1 0 0 0 6 0 no 0 10 0 0 0 0 0
ARTICLE -D-2-HG article A AR ART ARTI BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 0 0 1 0 0 0 0 0 6 0 --- 3 10 0 1 0 0 0
K. Hammon k. K K. K. K. BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 6 0 .. 2 2 0 1 0 0 0
tivity and tivity t ti tiv tivi BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 0 - 1 10 0 1 0 0 1
myeloid cells myeloid m my mye myel BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 0 - 1 9 0 1 0 0 1
presses MHC presses p pr pre pres BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 0 . 1 5 0 1 0 0 1
IDH-mutated acute idh-mutated I ID IDH IDH- BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 6 0 - 1 6 0 0 0 0 1
accumulate 2-hydroxyglutarate, accumulate a ac acc accu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 0 -,- 3 8 0 0 0 0 1
levels and levels l le lev leve BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 0 -- 2 8 0 0 0 0 1
To evaluate to T To To To BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 6 0 -- 2 8 0 0 0 0 1
on MHC on o on on on BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 0 , 1 9 0 0 0 0 1
expressing mutated expressing e ex exp expr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 0 -., 3 9 0 0 0 0 1
the endogenous the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 0 -'. 3 8 0 0 0 0 1
expected, 2-HG expected, e ex exp expe BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 0 ,-- 3 9 0 0 0 0 1
IDH2-mutated blasts idh2-mutated I ID IDH IDH2 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 0 --(-. 5 9 0 0 0 0 1
vs. IDH1-mutated vs. v vs vs. vs. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 0 .-..-.)(). 10 9 0 0 0 0 1
Analysis of analysis A An Ana Anal BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 6 0 no 0 8 0 0 0 0 1
revealed no revealed r re rev reve BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 0 - 1 9 0 0 0 0 1
wild-type AML wild-type w wi wil wild BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 0 --,-- 5 8 0 0 0 0 1
β gene β β β β β BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 1 0 0 0 0 0 0 0 6 0 (, 2 10 0 0 0 0 1
C). However, c). C C) C). C). BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 6 0 ).,,-(. 7 9 0 0 0 0 1
vs. 1.0) vs. v vs vs. vs. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 0 ..)-, 5 9 0 0 0 0 1
that of that t th tha that BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 0 -(..)-(..) 10 9 0 0 0 0 1
altered (Figure altered a al alt alte BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 0 (). 3 9 0 0 0 0 1
HLA-DP, overall hla-dp, H HL HLA HLA- BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 6 0 -,- 3 8 0 0 0 0 1
in AML in i in in in BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 6 0 (). 3 8 0 0 0 0 1
HLA-DP is hla-dp H HL HLA HLA- BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 6 0 ---- 4 9 0 0 0 0 1
sus-leukemia effects. sus-leukemia s su sus sus- BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 0 -.-- 4 8 0 0 0 0 1
tween patients tween t tw twe twee BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 0 - 1 8 0 0 0 0 1
clinically attractive clinically c cl cli clin BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 0 no 0 9 0 0 0 0 1
stem cell stem s st ste stem BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 0 no 0 8 0 0 0 0 1
HLA-DPB1-specific T hla-dpb1-specific H HL HLA HLA- BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 0 -- 2 9 0 0 0 0 1
allogeneic mismatched allogeneic a al all allo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 0 ., 2 8 0 0 0 0 1
we performed we w we we we BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 0 -- 2 9 0 0 0 0 1
the immune the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 0 --*: 4 8 0 0 0 0 1
blasts using blasts b bl bla blas BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 0 -*:-- 5 8 0 0 0 0 1
ic T-cell ic i ic ic ic BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 1 0 0 0 0 0 0 6 0 -. 2 9 0 0 0 0 1
the significantly the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 0 -, 2 8 0 0 0 0 1
HLA-DP-specific lysis hla-dp-specific H HL HLA HLA- BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 6 0 --- 3 9 0 0 0 0 1
receptor-modified T receptor-modified r re rec rece BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 0 -- 2 8 0 0 0 0 1
pared to pared p pa par pare BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 0 -(,). 5 9 0 0 0 0 1
Vitamin C vitamin V Vi Vit Vita BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 6 4 no 0 7 0 0 0 0 1
leukemia cells leukemia l le leu leuk BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 4 no 0 8 0 0 0 0 1
GNE140 upregulates gne140 G GN GNE GNE1 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 4 no 0 6 0 0 0 0 1
As GNE140 as A As As As BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 6 4 no 0 9 0 0 0 0 1
class II class c cl cla clas BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 4 ---, 4 8 0 0 0 0 1
whether GNE140 whether w wh whe whet BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 4 - 1 8 0 0 0 0 1
crease MHC crease c cr cre crea BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 4 . 1 9 0 0 0 0 1
of AML of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 4 ,, 2 10 0 0 0 0 1
cell survival, cell c ce cel cell BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 4 ,- 2 9 0 0 0 0 1
further diminished further f fu fur furt BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 4 , 1 9 0 0 0 0 1
in IDH-mutated in i in in in BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 6 4 -(-, 4 8 0 0 0 0 1
Figure S5A-C). figure F Fi Fig Figu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 6 4 -).- 4 9 0 0 0 0 1
cells tended cells c ce cel cell BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 4 ,- 2 9 0 0 0 0 1
increased after increased i in inc incr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 4 / 1 9 0 0 0 0 1
C (Figure c C C C C BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 6 4 (,).- 5 9 0 0 0 0 1
pression is pression p pr pre pres BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 6 no 0 10 0 1 0 0 1
not only not n no not not BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 6 -. 2 8 0 1 0 0 1
Discussion Discussion discussion D Di Dis Disc BLOCKSTART PAGEIN NEWFONT HIGHERFONT 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 7 6 no 0 10 0 0 0 0 1
Mutated IDH1 mutated M Mu Mut Muta BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 7 6 - 1 8 0 0 0 0 1
structurally similar structurally s st str stru BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 6 --, 3 9 0 0 0 0 1
several ketoglutarate-dependent several s se sev seve BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 6 -,, 3 9 0 0 0 0 1
limits histone limits l li lim limi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 6 , 1 9 0 0 0 0 1
impair hematopoietic impair i im imp impa BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 6 ., 2 9 0 0 0 0 1
analysis during analysis a an ana anal BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 6 no 0 9 0 0 0 0 1
DC also dc D DC DC DC BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 7 6 no 0 9 0 0 0 0 1
the presence the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 6 --.,- 5 9 0 0 0 0 1
α-KG-dependent dioxygenases, α-kg-dependent α α- α-K α-KG BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 6 --, 3 8 0 0 0 0 1
activity 31 activity a ac act acti BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 6 . 1 9 0 0 0 0 1
with vitamin with w wi wit with BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 6 no 0 9 0 0 0 0 1
carrying a carrying c ca car carr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 6 .- 2 9 0 0 0 0 1
periments, vitamin periments, p pe per peri BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 6 , 1 9 0 0 0 0 1
of D-2-HG of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 6 --,--- 6 8 0 0 0 0 1
induced and induced i in ind indu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 6 no 0 9 0 0 0 0 1
MYC expression myc M MY MYC MYC BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 7 6 . 1 5 0 0 0 0 1
Beyond epigenetic beyond B Be Bey Beyo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 7 6 , 1 8 0 0 0 0 1
demonstrated that demonstrated d de dem demo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 6 -- 2 8 0 0 0 0 1
L-2-HG has l-2-hg L L- L-2 L-2- BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 6 --(). 5 8 0 0 0 0 1
Both 2-HG both B Bo Bot Both BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 7 6 -( 2 8 0 0 0 0 1
V) in v) V V) V) V) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 7 6 )., 3 9 0 0 0 0 1
addition, primary addition, a ad add addi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 6 ,/- 3 9 0 0 0 0 1
ited lower ited i it ite ited BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 6 (). 3 9 0 0 0 0 1
contrast, our contrast, c co con cont BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 6 , 1 9 0 0 0 0 1
R132H and r132h R R1 R13 R132 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 6 - 1 9 0 0 0 0 1
tion rate. tion t ti tio tion BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 6 .,-- 4 9 0 0 0 0 1
increased basal increased i in inc incr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 6 -. 2 9 0 0 0 0 1
results have results r re res resu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 7 6 , 1 9 0 0 0 0 1
2-HG treatment 2-hg 2 2- 2-H 2-HG BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 6 -- 2 8 0 0 0 0 1
sis towards sis s si sis sis BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 6 ,- 2 9 0 0 0 0 1
cells might cells c ce cel cell BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 6 - 1 8 0 0 0 0 1
etic cells etic e et eti etic BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 6 ., 2 9 0 0 0 0 1
a recently a a a a a BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 1 0 1 0 0 0 0 0 7 6 ,- 2 9 0 0 0 0 1
showed higher showed s sh sho show BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 6 , 1 8 0 0 0 0 1
other tumor other o ot oth othe BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 6 .- 2 8 0 0 0 0 1
sides OXPHOS, sides s si sid side BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 7 6 , 1 8 0 0 0 0 1
of LDHB of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 6 - 1 8 0 0 0 0 1
line and line l li lin line BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 6 '-- 3 9 0 0 0 0 1
tion with tion t ti tio tion BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 6 -, 2 9 0 0 0 0 1
was supported. was w wa was was BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 6 ., 2 8 0 0 0 0 1
by promoter by b by by by BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 6 - 1 8 0 0 0 0 1
in turn in i in in in BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 7 6 . 1 10 0 0 0 0 1
suggest that suggest s su sug sugg BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 6 - 1 8 0 0 0 0 1
are both are a ar are are BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 6 --. 3 6 0 0 0 0 1
Our own our O Ou Our Our BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 7 6 -- 2 8 0 0 0 0 1
only OXPHOS only o on onl only BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 6 . 1 10 0 0 0 0 1
early phase early e ea ear earl BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 7 6 no 0 9 0 0 0 0 1
monocytes to monocytes m mo mon mono BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 6 . 1 9 0 0 0 0 1
metabolic shift metabolic m me met meta BLOCKEND PAGEEND SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 6 no 0 9 0 0 0 0 1
Haematologica | haematologica H Ha Hae Haem BLOCKSTART PAGESTART SAMEFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 7 0 no 0 10 0 0 1 0 0
2510 2510 2510 2 25 251 2510 BLOCKSTART PAGEIN NEWFONT HIGHERFONT 1 0 NOCAPS ALLDIGIT 0 0 0 0 1 0 0 0 7 0 no 0 10 0 0 0 0 0
ARTICLE -D-2-HG article A AR ART ARTI BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 0 0 1 0 0 0 0 0 7 0 --- 3 10 1 1 0 0 0
K. Hammon k. K K. K. K. BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 7 0 .. 2 2 1 1 0 0 0
Figure 5. figure F Fi Fig Figu BLOCKSTART PAGEIN SAMEFONT LOWERFONT 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 7 0 .-- 3 9 1 0 0 0 1
myeloid leukemia myeloid m my mye myel BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 0 .()-(-) 7 9 1 0 0 0 1
mass spectrometry mass m ma mas mass BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 0 ()-()(), 8 9 1 0 0 0 1
(N=6) or (n=6) ( (N (N= (N=6 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 0 ()().()(-,--) 13 9 1 0 0 0 1
expressing wild-type expressing e ex exp expr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 0 --(), 5 9 1 0 0 0 1
wild-type (N=155) wild-type w wi wil wild BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 0 -()-().() 9 9 1 0 0 0 1
data of data d da dat data BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 0 ().()(-[- 9 9 1 0 0 0 1
N=14, mutated n=14, N N= N=1 N=14 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 0 ,],-[-,]-[-,])- 15 9 1 0 0 0 1
ing mutated ing i in ing ing BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 1 0 0 0 0 0 0 7 0 -.()-() 7 9 1 0 0 0 1
or wild-type or o or or or BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 0 -()..()-*: 10 10 1 0 0 0 1
AML blasts aml A AM AML AML BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 7 0 -()() 5 9 1 0 0 0 1
cells expressing cells c ce cel cell BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 0 -*:--[] 7 10 1 0 0 0 1
A A a A A A A BLOCKSTART PAGEIN SAMEFONT HIGHERFONT 1 0 ALLCAP NODIGIT 1 0 1 0 0 0 0 0 7 11 no 0 10 1 0 0 0 1
D D d D D D D BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 7 11 no 0 10 0 0 0 0 1
F F f F F F F BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 7 11 no 0 10 0 0 0 0 1
G G g G G G G BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 7 11 no 0 10 0 0 0 0 1
E E e E E E E BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 7 11 no 0 10 0 0 0 0 1
B B b B B B B BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 7 11 no 0 10 1 0 0 0 1
C C c C C C C BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 7 11 no 0 10 1 0 0 0 1
Continued on continued C Co Con Cont BLOCKSTART PAGEEND NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 7 11 . 1 10 0 0 1 0 0
Haematologica | haematologica H Ha Hae Haem BLOCKSTART PAGESTART SAMEFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 7 0 no 0 10 0 0 1 0 0
2511 2511 2511 2 25 251 2511 BLOCKSTART PAGEIN NEWFONT HIGHERFONT 1 0 NOCAPS ALLDIGIT 0 0 0 0 1 0 0 0 7 0 no 0 10 0 0 0 0 0
ARTICLE -D-2-HG article A AR ART ARTI BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 0 0 1 0 0 0 0 0 7 0 --- 3 10 0 0 0 0 0
K. Hammon k. K K. K. K. BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 7 0 .. 2 2 0 0 0 0 0
lactic acid lactic l la lac lact BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 0 ,- 2 9 0 0 0 0 1
tic acid tic t ti tic tic BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 0 ., 2 9 0 0 0 0 1
later phase later l la lat late BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 0 , 1 9 0 0 0 0 1
crucial importance crucial c cr cru cruc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 0 . 1 9 0 0 0 0 1
The balance the T Th The The BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 7 0 no 0 8 0 0 0 0 1
control of control c co con cont BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 0 no 0 8 0 0 0 0 1
inducible factor-1α inducible i in ind indu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 0 -(-)., 6 10 0 0 0 0 1
have already have h ha hav have BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 0 no 0 8 0 0 0 0 1
8q24.21 with 8q24.21 8 8q 8q2 8q24 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 2 .-- 3 9 0 0 0 0 1
tant glioma tant t ta tan tant BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 2 . 1 4 0 0 0 0 1
O'Neill and o'neill O O' O'N O'Ne BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 0 0 0 0 0 0 8 2 '- 2 9 0 0 0 0 1
increased in increased i in inc incr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 2 -- 2 9 0 0 0 0 1
phages and phages p ph pha phag BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 2 no 0 9 0 0 0 0 1
through activation through t th thr thro BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 2 -. 2 10 0 0 0 0 1
our experiments, our o ou our our BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 2 ,-( 3 9 0 0 0 0 1
shown), but shown), s sh sho show BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 2 ), 2 9 0 0 0 0 1
the indicated the t th the the BLOCKSTART PAGEIN SAMEFONT LOWERFONT 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 4 ()--().-()() 12 9 1 1 0 0 1
blasts is blasts b bl bla blas BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 4 .(),().(-) 10 10 1 1 0 0 1
analyzed in analyzed a an ana anal BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 4 .-- 3 9 1 1 0 0 1
was used was w wa was was BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 4 ---.. 5 9 1 1 0 0 1
statistically significant statistically s st sta stat BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 4 (*.,**.).:-;:;:; 16 9 1 1 0 0 1
TCR: T-cell tcr: T TC TCR TCR: BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 8 4 :-;::--. 8 4 1 1 0 0 1
Figure 6. figure F Fi Fig Figu BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 8 7 . 1 10 1 1 0 0 1
combination with combination c co com comb BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 7 .-()() 6 9 1 1 0 0 1
(orange) were (orange) ( (o (or (ora BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 7 ()()() 6 10 1 1 0 0 1
µM GNE140, µm µ µM µM µM BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 7 ,.() 4 9 1 1 0 0 1
without treatment without w wi wit with BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 7 .()-() 6 9 1 1 0 0 1
mutant IDH mutant m mu mut muta BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 7 ().()()-()- 11 10 1 1 0 0 1
GNE140 on gne140 G GN GNE GNE1 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 7 ,,.-,- 6 9 1 1 0 0 1
Friedman test friedman F Fr Fri Frie BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 1 0 0 0 0 0 0 8 7 -..(*.,**.).: 13 9 1 1 0 0 1
wild-type; mut: wild-type; w wi wil wild BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 7 -;:;/:;:;:. 11 5 1 1 0 0 1
A A a A A A A BLOCKSTART PAGEIN SAMEFONT HIGHERFONT 1 0 ALLCAP NODIGIT 1 0 1 0 0 0 0 0 8 11 no 0 10 1 1 0 0 1
B B b B B B B BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 8 11 no 0 10 0 0 0 0 1
C C c C C C C BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 8 11 no 0 10 0 0 0 0 1
D D d D D D D BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 8 11 no 0 10 0 0 0 0 1
E E e E E E E BLOCKEND PAGEEND SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 8 11 no 0 10 0 0 0 0 1
Haematologica | haematologica H Ha Hae Haem BLOCKSTART PAGESTART NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 8 0 no 0 10 0 0 1 0 0
2512 2512 2512 2 25 251 2512 BLOCKSTART PAGEIN NEWFONT HIGHERFONT 1 0 NOCAPS ALLDIGIT 0 0 0 0 1 0 0 0 8 0 no 0 10 0 0 0 0 0
ARTICLE -D-2-HG article A AR ART ARTI BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 0 0 1 0 0 0 0 0 8 0 --- 3 10 0 1 0 0 0
K. Hammon k. K K. K. K. BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 8 0 .. 2 2 0 1 0 0 0
D-2-HG, which d-2-hg, D D- D-2 D-2- BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 0 --, 3 8 0 1 0 0 1
activity and activity a ac act acti BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 0 ., 2 9 0 1 0 0 1
tolerogenic DC tolerogenic t to tol tole BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 0 no 0 8 0 1 0 0 1
higher MYC higher h hi hig high BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 0 - 1 9 0 1 0 0 1
secretion. 45 secretion. s se sec secr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 0 .- 2 9 0 1 0 0 1
has been has h ha has has BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 0 ., 2 9 0 1 0 0 1
the transcription the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 0 /--, 4 9 0 1 0 0 1
which can which w wh whi whic BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 0 -., 3 9 0 1 0 0 1
that MYC that t th tha that BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 0 --- 3 9 0 1 0 0 1
levels and, levels l le lev leve BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 0 ,,- 3 9 0 1 0 0 1
DC. D-2-HG-treated dc. D DC DC. DC. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 8 0 .--- 4 8 0 1 0 0 1
day 4, day d da day day BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 8 0 , 1 8 0 1 0 0 1
induction and induction i in ind indu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 0 , 1 9 0 1 0 0 1
as LDHA as a as as as BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 0 --. 3 8 0 1 0 0 1
hand, LDHA hand, h ha han hand BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 0 , 1 8 0 1 0 0 1
might induce might m mi mig migh BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 0 , 1 9 0 1 0 0 1
deubiquitinase ubiquitin deubiquitinase d de deu deub BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 0 - 1 8 0 1 0 0 1
(USP28), which (usp28), ( (U (US (USP BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 0 (), 3 8 0 1 0 0 1
protein stabilization. protein p pr pro prot BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 0 ., 2 9 0 1 0 0 1
glycolytic inhibitors glycolytic g gl gly glyc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 0 no 0 8 0 1 0 0 1
upregulation of upregulation u up upr upre BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 0 (). 3 5 0 1 0 0 1
The higher the T Th The The BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 8 0 --- 3 9 0 1 0 0 1
explain the explain e ex exp expl BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 0 ,-- 3 8 0 1 0 0 1
expressing cells expressing e ex exp expr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 0 , 1 9 0 1 0 0 1
also reduces also a al als also BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 0 -. 2 9 0 1 0 0 1
relevance of relevance r re rel rele BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 0 - 1 9 0 1 0 0 1
is underlined is i is is is BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 0 no 0 8 0 1 0 0 1
IDH and idh I ID IDH IDH BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 8 0 - 1 8 0 1 0 0 1
class II class c cl cla clas BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 0 ., 2 10 0 1 0 0 1
as AML as a as as as BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 0 , 1 8 0 1 0 0 1
of their of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 0 no 0 8 0 1 0 0 1
molecules is molecules m mo mol mole BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 0 . 1 9 0 1 0 0 1
explain the explain e ex exp expl BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 0 no 0 8 0 1 0 0 1
IDH-mutated AML idh-mutated I ID IDH IDH- BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 8 0 --- 3 8 0 1 0 0 1
HG accumulation, hg H HG HG HG BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 8 0 ,- 2 9 0 1 0 0 1
and immune and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 0 .,- 3 9 0 1 0 0 1
by an by b by by by BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 0 ., 2 9 0 1 0 0 1
Friedrich et friedrich F Fr Fri Frie BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 0 0 0 0 0 0 8 0 .--- 4 8 0 1 0 0 1
the kynurenine the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 0 no 0 8 0 1 0 0 1
to re-education to t to to to BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 0 --.- 4 9 0 1 0 0 1
polysaccharide/interferon-stimulated human polysaccharide/interferon-stimulated p po pol poly BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 0 /- 2 8 0 1 0 0 1
D-2-HG also d-2-hg D D- D-2 D-2- BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 0 --- 3 9 0 1 0 0 1
partially reversed partially p pa par part BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 0 - 1 9 0 1 0 0 1
a murine a a a a a BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 1 0 1 0 0 0 0 0 8 0 ., 2 9 0 1 0 0 1
by Kadiyala by b by by by BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 0 .- 2 8 0 1 0 0 1
model in model m mo mod mode BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 0 no 0 8 0 1 0 0 1
DC infiltration dc D DC DC DC BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 8 0 . 1 9 0 1 0 0 1
IDH-related D-2-HG idh-related I ID IDH IDH- BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 8 0 ---- 4 8 0 1 0 0 1
bolic strategy bolic b bo bol boli BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 0 no 0 9 0 1 0 0 1
the anti-tumor the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 0 -. 2 3 0 1 0 0 1
The expression the T Th The The BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 8 0 - 1 8 0 1 0 0 1
portant for portant p po por port BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 0 , 1 9 0 1 0 0 1
for immune for f fo for for BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 0 . 1 8 0 1 0 0 1
the impact the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 0 - 1 8 0 1 0 0 1
patients and patients p pa pat pati BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 0 no 0 8 0 1 0 0 1
HLA-DP for hla-dp H HL HLA HLA- BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 9 6 --- 3 8 0 1 0 0 1
role in role r ro rol role BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 6 .,,,, 5 5 0 1 0 0 1
When testing when W Wh Whe When BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 9 6 ---- 4 9 0 1 0 0 1
mary AML mary m ma mar mary BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 0 0 0 0 0 0 9 6 ,- 2 8 0 1 0 0 1
poor T-cell poor p po poo poor BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 6 - 1 9 0 1 0 0 1
IDH. Further idh. I ID IDH IDH. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 9 6 .-- 3 8 0 1 0 0 1
stimulated glycolysis stimulated s st sti stim BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 6 no 0 8 0 1 0 0 1
in wild-type in i in in in BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 9 6 -., 3 8 0 1 0 0 1
and monocyte-derived and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 6 -, 2 9 0 1 0 0 1
much higher much m mu muc much BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 6 . 1 9 0 1 0 0 1
feature in feature f fe fea feat BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 6 . 1 9 0 1 0 0 1
also leads also a al als also BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 6 -, 2 9 0 1 0 0 1
interferes with interferes i in int inte BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 6 -., 3 10 0 1 0 0 1
targeting glycolysis targeting t ta tar targ BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 6 no 0 9 0 1 0 0 1
strategy not strategy s st str stra BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 6 , 1 9 0 1 0 0 1
closely associated closely c cl clo clos BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 6 . 1 7 0 1 0 0 1
We tested we W We We We BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 9 6 no 0 9 0 1 0 0 1
effects of effects e ef eff effe BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 6 -- 2 9 0 1 0 0 1
differentiation of differentiation d di dif diff BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 6 .- 2 9 0 1 0 0 1
pected, the pected, p pe pec pect BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 6 , 1 9 0 1 0 0 1
and supported and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 6 ,- 2 8 0 1 0 0 1
in DC in i in in in BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 9 6 . 1 8 0 1 0 0 1
Hence, the hence, H He Hen Henc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 9 6 ,-- 3 8 0 1 0 0 1
of differentiating of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 6 - 1 8 0 1 0 0 1
tered phenotype tered t te ter tere BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 6 ., 2 8 0 1 0 0 1
deacetylase inhibitors, deacetylase d de dea deac BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 6 , 1 9 0 1 0 0 1
can increase can c ca can can BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 6 no 0 8 0 1 0 0 1
cells. 57 cells. c ce cel cell BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 6 .-- 3 9 0 1 0 0 1
on DNA on o on on on BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 6 ,- 2 8 0 1 0 0 1
bined vitamin bined b bi bin bine BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 6 . 1 7 0 1 0 0 1
The co-treatment the T Th The The BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 9 6 - 1 8 0 1 0 0 1
effects on effects e ef eff effe BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 6 , 1 9 0 1 0 0 1
not fully not n no not not BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 6 . 1 9 0 1 0 0 1
were obtained were w we wer were BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 6 (-)- 4 9 0 1 0 0 1
gets both gets g ge get gets BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 6 ., 2 8 0 1 0 0 1
GNE140 administration gne140 G GN GNE GNE1 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 6 no 0 8 0 1 0 0 1
in AML in i in in in BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 9 6 ., 2 8 0 1 0 0 1
by vitamin by b by by by BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 6 . 1 9 0 1 0 0 1
concentrations of concentrations c co con conc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 6 no 0 9 0 1 0 0 1
cells. 58 cells. c ce cel cell BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 6 .- 2 9 0 1 0 0 1
port MHC port p po por port BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 6 , 1 9 0 1 0 0 1
immunity in immunity i im imm immu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 6 . 1 9 0 1 0 0 1
been shown been b be bee been BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 6 , 1 9 0 1 0 0 1
inhibitors or inhibitors i in inh inhi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 6 , 1 8 0 1 0 0 1
option to option o op opt opti BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 6 -- 2 8 0 1 0 0 1
IDH-mutated tumor idh-mutated I ID IDH IDH- BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 9 6 -., 3 9 0 1 0 0 1
In summary, in I In In In BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 1 0 0 0 0 0 9 6 ,-- 3 8 0 1 0 0 1
of DC of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 6 no 0 8 0 1 0 0 1
class II class c cl cla clas BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 6 no 0 9 0 1 0 0 1
reprogramming. A reprogramming. r re rep repr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 6 . 1 8 0 1 0 0 1
AML blasts aml A AM AML AML BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 9 6 -- 2 7 0 1 0 0 1
production. The production. p pr pro prod BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 6 . 1 8 0 1 0 0 1
antioxidant/epigenetic modulator antioxidant/epigenetic a an ant anti BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 6 /- 2 8 0 1 0 0 1
ly rescue ly l ly ly ly BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 0 0 0 0 0 0 9 6 -- 2 8 0 1 0 0 1
class II class c cl cla clas BLOCKEND PAGEEND SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 6 .- 2 8 0 1 0 0 1
Haematologica | haematologica H Ha Hae Haem BLOCKSTART PAGESTART SAMEFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 9 0 no 0 10 0 0 1 0 0
2513 2513 2513 2 25 251 2513 BLOCKSTART PAGEIN NEWFONT HIGHERFONT 1 0 NOCAPS ALLDIGIT 0 0 0 0 1 0 0 0 9 0 no 0 10 0 0 0 0 0
ARTICLE -D-2-HG article A AR ART ARTI BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 0 0 1 0 0 0 0 0 9 0 --- 3 10 0 0 0 0 0
K. Hammon k. K K. K. K. BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 9 0 .. 2 2 0 0 0 0 0
tion of tion t ti tio tion BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 0 - 1 10 0 0 0 0 1
chemotherapy for chemotherapy c ch che chem BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 0 no 0 9 0 0 0 0 1
leukemia that leukemia l le leu leuk BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 0 -- 2 9 0 0 0 0 1
the immune the t th the the BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 0 . 1 7 0 0 0 0 1
Disclosures Disclosures disclosures D Di Dis Disc BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 9 0 no 0 3 0 0 0 0 1
No conflicts no N No No No BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 9 0 . 1 10 0 0 0 0 1
Contributions Contributions contributions C Co Con Cont BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 9 0 no 0 2 0 1 0 0 1
MK, ST, mk, M MK MK, MK, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 9 0 ,,,.- 5 9 0 1 0 0 1
sible for sible s si sib sibl BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 0 .,,,,,,, 8 9 0 1 0 0 1
HS, SI, hs, H HS HS, HS, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 9 0 ,,,,. 5 9 0 1 0 0 1
KH, NB, kh, K KH KH, KH, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 9 0 ,,,,,, 6 9 0 1 0 0 1
visualization. MK visualization. v vi vis visu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 0 . 1 9 0 1 0 0 1
project administrator. project p pr pro proj BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 0 .,,,, 5 9 0 1 0 0 1
the study. the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 0 .,, 3 9 0 1 0 0 1
paper. MK, paper. p pa pap pape BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 0 .,,,,,,,,,,,, 13 10 0 1 0 0 1
WH, and wh, W WH WH, WH, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 9 0 ,, 2 9 0 1 0 0 1
the manuscript. the t th the the BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 0 . 1 2 0 1 0 0 1
Acknowledgments Acknowledgments acknowledgments A Ac Ack Ackn BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 9 2 no 0 2 0 0 0 0 1
We thank we W We We We BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 9 2 no 0 9 0 0 0 0 1
obtained from obtained o ob obt obta BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 2 . 1 9 0 0 0 0 1
technical assistance technical t te tec tech BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 2 , 1 8 0 0 0 0 1
Wehrstein, Johanna wehrstein, W We Weh Wehr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 9 2 ,. 2 8 0 0 0 0 1
thank all thank t th tha than BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 2 no 0 10 0 0 0 0 1
Institute for institute I In Ins Inst BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 9 2 . 1 9 0 0 0 0 1
Funding Funding funding F Fu Fun Fund BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 9 2 no 0 1 0 0 0 0 1
This study this T Th Thi This BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 9 2 - 1 9 0 0 0 0 1
schungsgemeinschaft (DFG, schungsgemeinschaft s sc sch schu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 2 (,), 4 8 0 0 0 0 1
project number project p pr pro proj BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 2 -(); 4 8 0 0 0 0 1
KFO 262 kfo K KF KFO KFO BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 9 2 (,,,) 5 9 0 0 0 0 1
Kröner-Fresenius Foundation kröner-fresenius K Kr Krö Krön BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 9 2 -(). 4 10 0 0 0 0 1
Data-sharing statement data-sharing D Da Dat Data BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 9 3 - 1 3 0 1 0 0 1
Data are data D Da Dat Data BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 9 3 . 1 9 0 1 0 0 1
to the to t to to to BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 3 no 0 10 0 1 0 0 1
Supplementary Information. supplementary S Su Sup Supp BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 9 3 . 1 4 0 1 0 0 1
References References references R Re Ref Refe BLOCKSTART PAGEIN NEWFONT HIGHERFONT 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 9 3 no 0 10 0 1 0 0 1
1. Dang 1. 1 1. 1. 1. BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 3 .,,. 4 9 0 1 0 0 1
toward development toward t to tow towa BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 3 .. 2 8 0 1 0 0 1
2016;27(4):599-608. 2016;27(4):599-608. 2016;27(4):599-608. 2 20 201 2016 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 9 3 ;():-. 6 2 0 1 0 0 1
2. Molenaar 2. 2 2. 2. 2. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 3 .,,,, 5 9 0 1 0 0 1
Bleeker FE. bleeker B Bl Ble Blee BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 9 3 . 1 8 0 1 0 0 1
dehydrogenase 1 dehydrogenase d de deh dehy BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 3 no 0 8 0 1 0 0 1
prolongation. Biochim prolongation. p pr pro prol BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 3 ..;():-. 8 8 0 1 0 0 1
3. Dang 3. 3 3. 3. 3. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 3 .,,,.- 6 8 0 1 0 0 1
mutations produce mutations m mu mut muta BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 3 -.. 3 6 0 1 0 0 1
2009;462(7274):739-744. 2009;462(7274):739-744. 2009;462(7274):739-744. 2 20 200 2009 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 9 3 ;():-. 6 3 0 1 0 0 1
4. Janin 4. 4 4. 4. 4. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 3 .,,,.- 6 9 0 1 0 0 1
production in production p pr pro prod BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 9 3 -- 2 8 0 1 0 0 1
leukemia: a leukemia: l le leu leuk BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 3 : 1 8 0 1 0 0 1
group. J group. g gr gro grou BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 3 ..;():-. 8 5 0 1 0 0 1
5. Terunuma 5. 5 5. 5. 5. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 3 .,,,.- 6 9 0 1 0 0 1
of 2-hydroxyglutarate of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 3 - 1 7 0 1 0 0 1
prognosis. J prognosis. p pr pro prog BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 3 ..;():-. 8 6 0 1 0 0 1
6. Shim 6. 6 6. 6. 6. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 3 .-,,,.--: 9 9 0 1 0 0 1
epigenetic modifier epigenetic e ep epi epig BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 3 no 0 8 0 1 0 0 1
cancer. Cancer cancer. c ca can canc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 3 ..;():-. 8 6 0 1 0 0 1
7. Ye 7. 7 7. 7. 7. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 3 .,-,.,,- 8 10 0 1 0 0 1
and L-2-hydroxyglutarates. and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 3 --..;():-. 10 8 0 1 0 0 1
8. Waitkus 8. 8 8. 8. 8. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 3 .,,. 4 9 0 1 0 0 1
potential of potential p po pot pote BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 3 .. 2 7 0 1 0 0 1
2018;34(2):186-195. 2018;34(2):186-195. 2018;34(2):186-195. 2 20 201 2018 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 9 3 ;():-. 6 2 0 1 0 0 1
9. Figueroa 9. 9 9. 9. 9. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 3 .,-,,. 6 8 0 1 0 0 1
IDH2 mutations idh2 I ID IDH IDH2 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 3 , 1 9 0 1 0 0 1
TET2 function, tet2 T TE TET TET2 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 3 ,. 2 9 0 1 0 0 1
Cell. 2010;18(6):553-567. cell. C Ce Cel Cell BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 9 3 .;():-. 7 3 0 1 0 0 1
10. Chaturvedi 10. 1 10 10. 10. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 3 .,,,. 5 9 0 1 0 0 1
promotes leukemogenesis promotes p pr pro prom BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 3 no 0 8 0 1 0 0 1
targeted in targeted t ta tar targ BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 3 ..;():-. 8 7 0 1 0 0 1
11. Losman 11. 1 11 11. 11. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 3 .-,,,.()-- 10 7 0 1 0 0 1
hydroxyglutarate is hydroxyglutarate h hy hyd hydr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 3 no 0 8 0 1 0 0 1
its effects its i it its its BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 3 ..;():-. 8 9 0 1 0 0 1
12. Tyrakis 12. 1 12 12. 12. BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 3 .,,,.-- 7 9 0 1 0 0 1
regulates CD8+ regulates r re reg regu BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 7 -.. 3 5 0 1 0 0 1
2016;540(7632):236-241. 2016;540(7632):236-241. 2016;540(7632):236-241. 2 20 201 2016 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 10 7 ;():-. 6 3 0 1 0 0 1
13. Bunse 13. 1 13 13. 13. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 7 .,,,. 5 9 0 1 0 0 1
cell immunity cell c ce cel cell BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 7 ()--. 5 8 0 1 0 0 1
Nat Med. nat N Na Nat Nat BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 0 0 0 0 0 0 10 7 .;():-. 7 4 0 1 0 0 1
14. Friedrich 14. 1 14 14. 14. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 7 .,,,. 5 8 0 1 0 0 1
metabolism drives metabolism m me met meta BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 7 no 0 8 0 1 0 0 1
in IDH-mutant in i in in in BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 10 7 -..;():-. 9 7 0 1 0 0 1
15. Zhang 15. 1 15 15. 15. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 7 .,,,, 5 9 0 1 0 0 1
TM, Lin tm, T TM TM, TM, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 10 7 ,.-- 4 9 0 1 0 0 1
IDH-mutant gliomas idh-mutant I ID IDH IDH- BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 7 -. 2 8 0 1 0 0 1
Cancer Res. cancer C Ca Can Canc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 10 7 .;():-. 7 4 0 1 0 0 1
16. Lutz 16. 1 16 16. 16. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 7 .,,,. 5 9 0 1 0 0 1
method for method m me met meth BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 7 no 0 9 0 1 0 0 1
cells from cells c ce cel cell BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 7 .. 2 6 0 1 0 0 1
1999;223(1):77-92. 1999;223(1):77-92. 1999;223(1):77-92. 1 19 199 1999 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 10 7 ;():-. 6 2 0 1 0 0 1
17. Rai 17. 1 17 17. 17. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 7 .,,,. 5 9 0 1 0 0 1
of potent, of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 7 ,-- 3 8 0 1 0 0 1
dehydrogenase (LDH). dehydrogenase d de deh dehy BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 7 ()..;():-. 10 7 0 1 0 0 1
18. Thomas 18. 1 18 18. 18. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 7 .,,,. 5 8 0 1 0 0 1
effector function effector e ef eff effe BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 7 -- 2 8 0 1 0 0 1
T-cell receptor t-cell T T- T-c T-ce BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 7 -:. 3 9 0 1 0 0 1
Eur J eur E Eu Eur Eur BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 7 .;():-. 7 5 0 1 0 0 1
19. Gnaiger 19. 1 19 19. 19. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 7 .,-,,, 6 9 0 1 0 0 1
R. Control r. R R. R. R. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 10 7 .. 2 9 0 1 0 0 1
Bioenerg Biomembr. bioenerg B Bi Bio Bioe BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 7 .;():-. 7 5 0 1 0 0 1
20. Grassinger 20. 2 20 20. 20. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 7 .,,,. 5 10 0 1 0 0 1
long term long l lo lon long BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 10 7 - 1 8 0 1 0 0 1
colony stimulating colony c co col colo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 7 no 0 8 0 1 0 0 1
sclerosis. Cytokine. sclerosis. s sc scl scle BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 7 ..;():-. 8 5 0 1 0 0 1
21. Klug 21. 2 21 21. 21. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 7 .,,,,. 6 8 0 1 0 0 1
5-Hydroxymethylcytosine is 5-hydroxymethylcytosine 5 5- 5-H 5-Hy BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 7 - 1 8 0 1 0 0 1
DNA demethylation dna D DN DNA DNA BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 10 7 . 1 7 0 1 0 0 1
Genome Biol. genome G Ge Gen Geno BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 7 .;():. 6 4 0 1 0 0 1
22. Ugele 22. 2 22 22. 22. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 7 .,-,,.-- 8 7 0 1 0 0 1
hydroxyglutarate and hydroxyglutarate h hy hyd hydr BLOCKEND PAGEEND SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 7 --- 3 7 0 1 0 0 1
Haematologica | haematologica H Ha Hae Haem BLOCKSTART PAGESTART SAMEFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 0 no 0 10 0 0 1 0 0
2514 2514 2514 2 25 251 2514 BLOCKSTART PAGEIN NEWFONT HIGHERFONT 1 0 NOCAPS ALLDIGIT 0 0 0 0 1 0 0 0 10 0 no 0 10 0 0 0 0 0
ARTICLE -D-2-HG article A AR ART ARTI BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 0 0 1 0 0 0 0 0 10 0 --- 3 10 0 1 0 0 0
K. Hammon k. K K. K. K. BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 10 0 .. 2 2 0 1 0 0 0
secretion by secretion s se sec secr BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 0 -. 2 9 0 1 0 0 1
Sci. 2019;20(3):742. sci. S Sc Sci Sci. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 0 .;():. 6 3 0 1 0 0 1
23. Pearce 23. 2 23 23. 23. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 0 .,.. 4 8 0 1 0 0 1
Immunol. 2015;15(1):18-29. immunol. I Im Imm Immu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 0 .;():-. 7 3 0 1 0 0 1
24. Reinfeld 24. 2 24 24. 24. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 0 .,,,.- 6 8 0 1 0 0 1
nutrient partitioning nutrient n nu nut nutr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 0 .. 2 8 0 1 0 0 1
2021;593(7858):282-288. 2021;593(7858):282-288. 2021;593(7858):282-288. 2 20 202 2021 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 10 0 ;():-. 6 3 0 1 0 0 1
25. Shim 25. 2 25 25. 25. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 0 .,,,.- 6 9 0 1 0 0 1
LDH-A: implications ldh-a: L LD LDH LDH- BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 10 0 -:. 3 8 0 1 0 0 1
Natl Acad natl N Na Nat Natl BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 0 .;():-. 7 6 0 1 0 0 1
26. Boudreau 26. 2 26 26. 26. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 0 .,,,. 5 9 0 1 0 0 1
underpins innate underpins u un und unde BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 0 . 1 8 0 1 0 0 1
Nat Chem nat N Na Nat Nat BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 0 0 0 0 0 0 10 0 .;():-. 7 5 0 1 0 0 1
27. Gottfried 27. 2 27 27. 27. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 0 .,-,,.- 7 9 0 1 0 0 1
lactic acid lactic l la lac lact BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 0 no 0 8 0 1 0 0 1
expression. Blood. expression. e ex exp expr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 0 ..;():-. 8 6 0 1 0 0 1
28. Laghmouchi 28. 2 28 28. 28. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 0 .,,,, 5 8 0 1 0 0 1
Jedema I. jedema J Je Jed Jede BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 0 .--- 4 8 0 1 0 0 1
provoked by provoked p pr pro prov BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 0 no 0 8 0 1 0 0 1
show restricted show s sh sho show BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 0 no 0 8 0 1 0 0 1
primary malignant primary p pr pri prim BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 0 ..;():-. 8 8 0 1 0 0 1
29. Herr 29. 2 29 29. 29. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 0 .,,,.- 6 9 0 1 0 0 1
represent powerful represent r re rep repr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 0 - 1 8 0 1 0 0 1
immunotherapy after immunotherapy i im imm immu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 0 -. 2 8 0 1 0 0 1
Leukemia. 2017;31(2):434-445. leukemia. L Le Leu Leuk BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 0 .;():-. 7 4 0 1 0 0 1
30. Klobuch 30. 3 30 30. 30. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 0 .,,-,.- 7 8 0 1 0 0 1
reactive T reactive r re rea reac BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 0 no 0 8 0 1 0 0 1
allogeneic stem allogeneic a al all allo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 0 ..;():. 7 8 0 1 0 0 1
31. Blaschke 31. 3 31 31. 31. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 0 .,,,. 5 8 0 1 0 0 1
Tet-dependent DNA tet-dependent T Te Tet Tet- BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 0 -- 2 8 0 1 0 0 1
in ES in i in in in BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 10 0 ..;():-. 8 6 0 1 0 0 1
32. Gerecke 32. 3 32 32. 32. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 0 .,,,,. 6 8 0 1 0 0 1
Vitamin C vitamin V Vi Vit Vita BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 10 0 no 0 8 0 1 0 0 1
synergistically activates synergistically s sy syn syne BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 0 no 0 8 0 1 0 0 1
modulates gene modulates m mo mod modu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 0 .. 2 8 0 1 0 0 1
2020;15(3):307-322. 2020;15(3):307-322. 2020;15(3):307-322. 2 20 202 2020 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 10 0 ;():-. 6 2 0 1 0 0 1
33. Fu 33. 3 33 33. 33. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 0 .,,,.- 6 10 0 1 0 0 1
synthase and synthase s sy syn synt BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 0 ..;():-. 8 8 0 1 0 0 1
34. Kölker 34. 3 34 34. 34. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 0 .,,,. 5 10 0 1 0 0 1
and respiratory and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 0 no 0 8 0 1 0 0 1
neurodegeneration in neurodegeneration n ne neu neur BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 0 --. 3 8 0 1 0 0 1
Neurosci. 2002;16(1):21-28. neurosci. N Ne Neu Neur BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 0 .;():-. 7 4 0 1 0 0 1
35. Chan 35. 3 35 35. 35. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 0 .,,-,. 6 8 0 1 0 0 1
dehydrogenase 1 dehydrogenase d de deh dehy BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 0 - 1 8 0 1 0 0 1
acute myeloid acute a ac acu acut BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 0 ..;():-. 8 7 0 1 0 0 1
36. Böttcher 36. 3 36 36. 36. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 0 .,,,.-- 7 9 0 1 0 0 1
interferes with interferes i in int inte BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 0 -- 2 8 0 1 0 0 1
towards oxidative towards t to tow towa BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 0 no 0 7 0 1 0 0 1
polarization. Oncoimmunology. polarization. p po pol pola BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 0 ..;():. 7 7 0 1 0 0 1
37. Stuani 37. 3 37 37. 37. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 0 .,,,. 5 9 0 1 0 0 1
supports resistance supports s su sup supp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 0 no 0 8 0 1 0 0 1
leukemia. J leukemia. l le leu leuk BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 0 ..;():. 7 6 0 1 0 0 1
38. Navis 38. 3 38 38. 38. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 0 .,,,. 5 9 0 1 0 0 1
activity in activity a ac act acti BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 0 - 1 8 0 1 0 0 1
xenograft model: xenograft x xe xen xeno BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 0 :--. 4 8 0 1 0 0 1
Neuropathol Commun. neuropathol N Ne Neu Neur BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 0 .;:. 4 4 0 1 0 0 1
39. Qing 39. 3 39 39. 39. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 0 .,,,.-- 7 9 0 1 0 0 1
aerobic glycolysis aerobic a ae aer aero BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 0 /// 3 8 0 1 0 0 1
LDHB axis. ldhb L LD LDH LDHB BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 10 0 ..;():-.. 9 6 0 1 0 0 1
40. Chesnelong 40. 4 40 40. 40. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 0 .,,,. 5 8 0 1 0 0 1
dehydrogenase A dehydrogenase d de deh dehy BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 0 .. 2 8 0 1 0 0 1
2014;16(5):686-695. 2014;16(5):686-695. 2014;16(5):686-695. 2 20 201 2014 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 10 0 ;():-. 6 2 0 1 0 0 1
41. Guak 41. 4 41 41. 41. BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 0 .,,,. 5 9 0 1 0 0 1
essential for essential e es ess esse BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 6 . 1 9 0 1 0 0 1
Nat Commun. nat N Na Nat Nat BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 0 0 0 0 0 0 11 6 .;():. 6 4 0 1 0 0 1
42. Goetzman 42. 4 42 42. 42. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 6 .,. 3 9 0 1 0 0 1
glycolysis, oxidative glycolysis, g gl gly glyc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 11 6 ,,, 3 9 0 1 0 0 1
acid metabolism acid a ac aci acid BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 6 . 1 8 0 1 0 0 1
Endocrinol (Lausanne). endocrinol E En End Endo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 11 6 ().;:. 6 5 0 1 0 0 1
43. Oktay 43. 4 43 43. 43. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 6 .,,,.- 6 9 0 1 0 0 1
association of association a as ass asso BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 6 . 1 8 0 1 0 0 1
deregulation. Sci deregulation. d de der dere BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 6 ..;:. 5 5 0 1 0 0 1
44. Williams 44. 4 44 44. 44. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 6 .,,,. 5 9 0 1 0 0 1
L-2-hydroxyglutarate activates l-2-hydroxyglutarate L L- L-2 L-2- BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 6 --- 3 9 0 1 0 0 1
lipopolysaccharide-activated macrophages. lipopolysaccharide-activated l li lip lipo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 11 6 -.. 3 7 0 1 0 0 1
2022;298(2):101501. 2022;298(2):101501. 2022;298(2):101501. 2 20 202 2022 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 11 6 ;():. 5 2 0 1 0 0 1
45. García-González 45. 4 45 45. 45. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 6 .-,,,. 6 10 0 1 0 0 1
tolerogenic features tolerogenic t to tol tole BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 11 6 -- 2 7 0 1 0 0 1
activated dendritic activated a ac act acti BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 6 ..;:. 5 9 0 1 0 0 1
46. Qiu 46. 4 46 46. 46. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 6 .,-,,. 6 9 0 1 0 0 1
L2HGDH influences l2hgdh L L2 L2H L2HG BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 6 . 1 8 0 1 0 0 1
Chem Biol. chem C Ch Che Chem BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 11 6 .;():-.. 8 4 0 1 0 0 1
47. Cui 47. 4 47 47. 47. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 6 .,,,.- 6 9 0 1 0 0 1
lactate dehydrogenase lactate l la lac lact BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 11 6 - 1 8 0 1 0 0 1
cells. J cells. c ce cel cell BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 6 ..;():-. 8 6 0 1 0 0 1
48. God 48. 4 48 48. 48. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 6 .,,,.- 6 8 0 1 0 0 1
disrupts HLA disrupts d di dis disr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 6 - 1 8 0 1 0 0 1
cell tumors. cell c ce cel cell BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 6 ..;():-. 8 6 0 1 0 0 1
49. Masuda 49. 4 49 49. 49. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 6 .,,,.- 6 9 0 1 0 0 1
HLA class hla H HL HLA HLA BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 11 6 no 0 9 0 1 0 0 1
leukemic blasts. leukemic l le leu leuk BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 11 6 ..;():-. 8 7 0 1 0 0 1
50. Christopher 50. 5 50 50. 50. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 6 .,,,. 5 9 0 1 0 0 1
relapsed AML relapsed r re rel rela BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 6 . 1 8 0 1 0 0 1
Med. 2018;379(24):2330-2341. med. M Me Med Med. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 11 6 .;():-. 7 4 0 1 0 0 1
51. Kohanbash 51. 5 51 51. 51. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 6 .,,,. 5 8 0 1 0 0 1
dehydrogenase mutations dehydrogenase d de deh dehy BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 11 6 no 0 7 0 1 0 0 1
accumulation in accumulation a ac acc accu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 6 ..;():-. 8 9 0 1 0 0 1
52. Kadiyala 52. 5 52 52. 52. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 6 .,,,. 5 8 0 1 0 0 1
2-hydroxyglutarate elicits 2-hydroxyglutarate 2 2- 2-h 2-hy BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 6 - 1 8 0 1 0 0 1
IDH1 glioma idh1 I ID IDH IDH1 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 6 ..;():. 7 9 0 1 0 0 1
53. Fleischhauer 53. 5 53 53. 53. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 6 .,.- 4 9 0 1 0 0 1
cell transplantation cell c ce cel cell BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 6 :. 2 8 0 1 0 0 1
Blood. 2017;130(9):1089-1096. blood. B Bl Blo Bloo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 11 6 .;():-. 7 4 0 1 0 0 1
54. Toffalori 54. 5 54 54. 54. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 6 .,,,. 5 10 0 1 0 0 1
leukemia escape leukemia l le leu leuk BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 11 6 no 0 7 0 1 0 0 1
transplantation. Nat transplantation. t tr tra tran BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 11 6 ..;():-. 8 6 0 1 0 0 1
55. Chen 55. 5 55 55. 55. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 6 .-,-,-,. 8 8 0 1 0 0 1
metabolism signature metabolism m me met meta BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 6 no 0 7 0 1 0 0 1
prognostic value. prognostic p pr pro prog BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 11 6 ..;():-. 8 7 0 1 0 0 1
56. Uhl 56. 5 56 56. 56. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 6 .,,',. 6 9 0 1 0 0 1
donor T donor d do don dono BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 6 -- 2 8 0 1 0 0 1
and humans. and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 6 ..;():. 7 7 0 1 0 0 1
57. Turner 57. 5 57 57. 57. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 6 .,-,,. 6 9 0 1 0 0 1
upregulate MHC upregulate u up upr upre BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 11 6 . 1 8 0 1 0 0 1
Oncotarget. 2017;8(27):44159-44170. oncotarget. O On Onc Onco BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 11 6 .;():-. 7 5 0 1 0 0 1
58. Chen 58. 5 58 58. 58. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 6 .,,,. 5 9 0 1 0 0 1
acid concentrations acid a ac aci acid BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 6 : 1 9 0 1 0 0 1
pro-drug to pro-drug p pr pro pro- BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 6 -. 2 9 0 1 0 0 1
Sci U sci S Sc Sci Sci BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 11 6 .;():-. 7 5 0 1 0 0 1
59. Molenaar 59. 5 59 59. 59. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 6 .,,,. 5 9 0 1 0 0 1
IDH1-mutated cancer idh1-mutated I ID IDH IDH1 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 6 --- 3 8 0 1 0 0 1
5198. Cancer 5198. 5 51 519 5198 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 6 ..;():-. 8 5 0 1 0 0 1
60. Molenaar 60. 6 60 60. 60. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 6 .,,,./ 6 9 0 1 0 0 1
sensitize acute sensitize s se sen sens BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 11 6 no 0 9 0 1 0 0 1
reversed by reversed r re rev reve BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 6 /-.. 4 7 0 1 0 0 1
2018;24(7):1705-1715. 2018;24(7):1705-1715. 2018;24(7):1705-1715. 2 20 201 2018 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 11 6 ;():-. 6 3 0 1 0 0 1

